Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-125b-5p ERBB3 -1.16 0.00029 1.03 0.01096 miRNAWalker2 validate; miRTarBase -0.38 0 NA
2 hsa-miR-299-5p ERBB3 -0.27 0.38683 1.03 0.01096 MirTarget -0.18 0.0044 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF CELL PROLIFERATION 136 1496 1.78e-59 8.284e-56
2 POSITIVE REGULATION OF RESPONSE TO STIMULUS 149 1929 1.3e-56 3.024e-53
3 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 145 1848 1.07e-55 1.66e-52
4 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 127 1395 4.251e-55 4.945e-52
5 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 134 1672 6.609e-52 6.151e-49
6 TISSUE DEVELOPMENT 127 1518 6.436e-51 4.991e-48
7 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 89 689 6.751e-50 4.488e-47
8 REGULATION OF CELLULAR COMPONENT MOVEMENT 93 771 1.254e-49 7.293e-47
9 REGULATION OF CELL DEATH 123 1472 4.691e-49 2.425e-46
10 POSITIVE REGULATION OF CELL PROLIFERATION 94 814 1.621e-48 7.54e-46
11 LOCOMOTION 107 1114 8.108e-48 3.429e-45
12 RESPONSE TO ENDOGENOUS STIMULUS 117 1450 7.901e-45 3.064e-42
13 POSITIVE REGULATION OF MOLECULAR FUNCTION 129 1791 1.654e-44 5.919e-42
14 INTRACELLULAR SIGNAL TRANSDUCTION 121 1572 2.2e-44 7.313e-42
15 REGULATION OF CELL ADHESION 80 629 3.978e-44 1.234e-41
16 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 123 1656 1.446e-43 4.207e-41
17 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 103 1142 2.361e-43 6.461e-41
18 IMMUNE SYSTEM PROCESS 134 1984 2.591e-43 6.697e-41
19 REGULATION OF CELL DIFFERENTIATION 116 1492 8.931e-43 2.187e-40
20 CELL MOTILITY 88 835 5.17e-42 1.145e-39
21 LOCALIZATION OF CELL 88 835 5.17e-42 1.145e-39
22 REGULATION OF IMMUNE SYSTEM PROCESS 111 1403 1.82e-41 3.849e-39
23 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 106 1275 2.08e-41 4.208e-39
24 CARDIOVASCULAR SYSTEM DEVELOPMENT 85 788 2.672e-41 4.974e-39
25 CIRCULATORY SYSTEM DEVELOPMENT 85 788 2.672e-41 4.974e-39
26 RESPONSE TO EXTERNAL STIMULUS 125 1821 9.982e-41 1.786e-38
27 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 94 1008 1.628e-40 2.805e-38
28 CELL DEVELOPMENT 110 1426 5.186e-40 8.618e-38
29 RESPONSE TO GROWTH FACTOR 66 475 1.192e-38 1.912e-36
30 POSITIVE REGULATION OF CELL COMMUNICATION 112 1532 1.397e-38 2.166e-36
31 POSITIVE REGULATION OF GENE EXPRESSION 119 1733 1.539e-38 2.31e-36
32 NEGATIVE REGULATION OF CELL DEATH 85 872 6.803e-38 9.892e-36
33 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 91 1021 1.486e-37 2.096e-35
34 RESPONSE TO OXYGEN CONTAINING COMPOUND 105 1381 1.845e-37 2.524e-35
35 VASCULATURE DEVELOPMENT 64 469 5.563e-37 7.396e-35
36 POSITIVE REGULATION OF LOCOMOTION 61 420 7.913e-37 1.023e-34
37 ORGAN MORPHOGENESIS 82 841 1.661e-36 2.089e-34
38 POSITIVE REGULATION OF CELL DIFFERENTIATION 81 823 2.44e-36 2.911e-34
39 REGULATION OF PHOSPHORUS METABOLIC PROCESS 112 1618 2.407e-36 2.911e-34
40 REGULATION OF PROTEIN MODIFICATION PROCESS 115 1710 3.16e-36 3.676e-34
41 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 107 1492 6.156e-36 6.986e-34
42 RESPONSE TO WOUNDING 68 563 6.655e-36 7.372e-34
43 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 94 1152 1.021e-35 1.105e-33
44 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 86 957 1.186e-35 1.226e-33
45 CELL ACTIVATION 68 568 1.169e-35 1.226e-33
46 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 82 867 1.554e-35 1.572e-33
47 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 86 983 9.017e-35 8.926e-33
48 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 116 1805 1.079e-34 1.046e-32
49 POSITIVE REGULATION OF CELL ADHESION 56 376 2.132e-34 2.024e-32
50 BLOOD VESSEL MORPHOGENESIS 55 364 4.028e-34 3.749e-32
51 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 91 1135 6.577e-34 6.001e-32
52 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 87 1036 7.596e-34 6.668e-32
53 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 87 1036 7.596e-34 6.668e-32
54 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 80 876 1.488e-33 1.282e-31
55 WOUND HEALING 60 470 5.357e-33 4.532e-31
56 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 61 498 1.616e-32 1.343e-30
57 NEUROGENESIS 99 1402 1.801e-32 1.47e-30
58 RESPONSE TO LIPID 79 888 2.503e-32 2.008e-30
59 TISSUE MORPHOGENESIS 62 533 9.341e-32 7.367e-30
60 POSITIVE REGULATION OF CATALYTIC ACTIVITY 102 1518 1.023e-31 7.931e-30
61 IMMUNE SYSTEM DEVELOPMENT 64 582 2.396e-31 1.828e-29
62 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 73 799 1.526e-30 1.145e-28
63 LEUKOCYTE ACTIVATION 54 414 3.503e-30 2.588e-28
64 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 94 1360 5.418e-30 3.939e-28
65 LEUKOCYTE DIFFERENTIATION 46 292 2.055e-29 1.471e-27
66 ANGIOGENESIS 46 293 2.398e-29 1.691e-27
67 REGULATION OF CELL DEVELOPMENT 73 836 2.755e-29 1.913e-27
68 REGULATION OF MAPK CASCADE 65 660 5.062e-29 3.413e-27
69 SKELETAL SYSTEM DEVELOPMENT 55 455 5.005e-29 3.413e-27
70 EXTRACELLULAR STRUCTURE ORGANIZATION 46 304 1.262e-28 8.387e-27
71 REGULATION OF IMMUNE RESPONSE 73 858 1.427e-28 9.352e-27
72 EPITHELIUM DEVELOPMENT 76 945 3.51e-28 2.269e-26
73 PROTEIN PHOSPHORYLATION 74 944 1.011e-26 6.442e-25
74 EMBRYO DEVELOPMENT 72 894 1.062e-26 6.679e-25
75 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 68 801 1.59e-26 9.863e-25
76 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 76 1004 1.716e-26 1.05e-24
77 LYMPHOCYTE ACTIVATION 46 342 2.339e-26 1.413e-24
78 REGULATION OF CELL CELL ADHESION 48 380 3.064e-26 1.828e-24
79 MORPHOGENESIS OF AN EPITHELIUM 49 400 3.648e-26 2.149e-24
80 REGULATION OF HYDROLASE ACTIVITY 87 1327 5.202e-26 3.026e-24
81 REGULATION OF CELL ACTIVATION 53 484 6.983e-26 4.011e-24
82 REGULATION OF KINASE ACTIVITY 66 776 8.782e-26 4.983e-24
83 REGULATION OF RESPONSE TO STRESS 91 1468 1.673e-25 9.381e-24
84 RESPONSE TO HORMONE 70 893 3e-25 1.662e-23
85 NEGATIVE REGULATION OF CELL COMMUNICATION 81 1192 3.698e-25 2.024e-23
86 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 45 352 7.382e-25 3.994e-23
87 RESPONSE TO CYTOKINE 62 714 1.072e-24 5.733e-23
88 IMMUNE RESPONSE 77 1100 1.101e-24 5.823e-23
89 POSITIVE REGULATION OF CELL DEVELOPMENT 51 472 1.188e-24 6.213e-23
90 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 43 321 1.308e-24 6.762e-23
91 RESPONSE TO ORGANIC CYCLIC COMPOUND 70 917 1.427e-24 7.294e-23
92 REGULATION OF CYTOKINE PRODUCTION 55 563 2.159e-24 1.092e-22
93 TAXIS 50 464 4.003e-24 2.003e-22
94 BIOLOGICAL ADHESION 73 1032 1.209e-23 5.986e-22
95 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 98 1784 1.336e-23 6.543e-22
96 POSITIVE REGULATION OF HYDROLASE ACTIVITY 68 905 1.794e-23 8.697e-22
97 TUBE DEVELOPMENT 53 552 3.641e-23 1.747e-21
98 NEGATIVE REGULATION OF CELL PROLIFERATION 57 643 3.699e-23 1.756e-21
99 PHOSPHORYLATION 79 1228 5.236e-23 2.461e-21
100 UROGENITAL SYSTEM DEVELOPMENT 40 299 6.313e-23 2.938e-21
101 NEURON DIFFERENTIATION 66 874 6.755e-23 3.112e-21
102 SINGLE ORGANISM CELL ADHESION 48 459 1.29e-22 5.884e-21
103 RESPONSE TO NITROGEN COMPOUND 65 859 1.348e-22 6.09e-21
104 POSITIVE REGULATION OF KINASE ACTIVITY 49 482 1.554e-22 6.954e-21
105 REGULATION OF HOMOTYPIC CELL CELL ADHESION 40 307 1.716e-22 7.603e-21
106 CONNECTIVE TISSUE DEVELOPMENT 33 194 1.99e-22 8.736e-21
107 POSITIVE REGULATION OF CELL ACTIVATION 40 311 2.795e-22 1.215e-20
108 POSITIVE REGULATION OF CELL CELL ADHESION 36 243 2.97e-22 1.28e-20
109 CELLULAR RESPONSE TO LIPID 47 457 7.495e-22 3.199e-20
110 REGULATION OF TRANSFERASE ACTIVITY 67 946 1.042e-21 4.409e-20
111 MESENCHYME DEVELOPMENT 32 190 1.214e-21 5.088e-20
112 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 44 404 1.726e-21 7.17e-20
113 CELL PROLIFERATION 56 672 1.824e-21 7.51e-20
114 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 28 138 2.287e-21 9.336e-20
115 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 49 513 2.34e-21 9.466e-20
116 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 47 470 2.434e-21 9.762e-20
117 LEUKOCYTE MIGRATION 36 259 2.704e-21 1.075e-19
118 RESPONSE TO BIOTIC STIMULUS 64 886 3.493e-21 1.377e-19
119 RAS PROTEIN SIGNAL TRANSDUCTION 28 143 6.367e-21 2.489e-19
120 CELLULAR COMPONENT MORPHOGENESIS 64 900 7.929e-21 3.075e-19
121 REGULATION OF EPITHELIAL CELL PROLIFERATION 37 285 8.095e-21 3.113e-19
122 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 58 750 1.237e-20 4.718e-19
123 CARTILAGE DEVELOPMENT 28 147 1.4e-20 5.298e-19
124 LEUKOCYTE CELL CELL ADHESION 35 255 1.51e-20 5.667e-19
125 EMBRYONIC MORPHOGENESIS 49 539 1.949e-20 7.257e-19
126 NEGATIVE REGULATION OF CELL DIFFERENTIATION 52 609 1.969e-20 7.272e-19
127 POSITIVE REGULATION OF IMMUNE RESPONSE 50 563 2.112e-20 7.739e-19
128 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 98 1977 2.349e-20 8.539e-19
129 LYMPHOCYTE DIFFERENTIATION 32 209 2.439e-20 8.798e-19
130 MORPHOGENESIS OF A BRANCHING STRUCTURE 29 167 4.229e-20 1.513e-18
131 REGULATION OF NEURON DIFFERENTIATION 49 554 6.251e-20 2.22e-18
132 REGULATION OF TRANSPORT 92 1804 7.429e-20 2.619e-18
133 TUBE MORPHOGENESIS 38 323 7.699e-20 2.694e-18
134 DEFENSE RESPONSE 74 1231 8.222e-20 2.855e-18
135 PEPTIDYL TYROSINE MODIFICATION 30 186 8.432e-20 2.906e-18
136 POSITIVE REGULATION OF MAPK CASCADE 45 470 1.039e-19 3.555e-18
137 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 30 190 1.578e-19 5.36e-18
138 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 63 926 1.591e-19 5.363e-18
139 RESPONSE TO BACTERIUM 47 528 2.95e-19 9.874e-18
140 REGULATION OF CELL MORPHOGENESIS 48 552 3.123e-19 1.038e-17
141 POSITIVE REGULATION OF CELL DEATH 50 605 4.591e-19 1.515e-17
142 SENSORY ORGAN DEVELOPMENT 45 493 6.809e-19 2.231e-17
143 REGULATION OF CELLULAR COMPONENT BIOGENESIS 56 767 8.846e-19 2.878e-17
144 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 50 616 9.827e-19 3.175e-17
145 STEM CELL DIFFERENTIATION 29 190 1.691e-18 5.427e-17
146 REGULATION OF HEMOPOIESIS 36 314 1.78e-18 5.674e-17
147 REGENERATION 27 161 2.185e-18 6.915e-17
148 HEART DEVELOPMENT 43 466 2.89e-18 9.087e-17
149 REGULATION OF MAP KINASE ACTIVITY 36 319 2.995e-18 9.352e-17
150 CELL CELL ADHESION 49 608 3.034e-18 9.412e-17
151 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 30 213 4.363e-18 1.345e-16
152 GROWTH 40 410 6.701e-18 2.051e-16
153 GLAND DEVELOPMENT 39 395 1.179e-17 3.586e-16
154 CELLULAR RESPONSE TO CYTOKINE STIMULUS 48 606 1.39e-17 4.2e-16
155 CELL PROJECTION ORGANIZATION 59 902 1.684e-17 5.055e-16
156 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 36 337 1.798e-17 5.362e-16
157 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 26 162 2.922e-17 8.66e-16
158 AGING 32 264 2.974e-17 8.76e-16
159 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 39 406 3.032e-17 8.872e-16
160 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 29 211 3.152e-17 9.167e-16
161 NEURON PROJECTION DEVELOPMENT 45 545 3.255e-17 9.408e-16
162 CELLULAR RESPONSE TO BIOTIC STIMULUS 26 163 3.419e-17 9.82e-16
163 MESENCHYMAL CELL DIFFERENTIATION 24 134 3.666e-17 1.047e-15
164 POSITIVE REGULATION OF NEURON DIFFERENTIATION 34 306 4.385e-17 1.244e-15
165 POSITIVE REGULATION OF CYTOKINE PRODUCTION 37 370 5.57e-17 1.571e-15
166 CELLULAR RESPONSE TO NITROGEN COMPOUND 43 505 5.67e-17 1.589e-15
167 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 45 554 6.058e-17 1.688e-15
168 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 40 437 6.246e-17 1.72e-15
169 REGULATION OF NEURON DEATH 31 252 6.212e-17 1.72e-15
170 CENTRAL NERVOUS SYSTEM DEVELOPMENT 57 872 6.581e-17 1.801e-15
171 HEAD DEVELOPMENT 51 709 6.987e-17 1.901e-15
172 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 41 465 9.344e-17 2.528e-15
173 NEPHRON DEVELOPMENT 22 115 1.797e-16 4.834e-15
174 REGULATION OF BINDING 32 283 2.298e-16 6.147e-15
175 MUSCLE STRUCTURE DEVELOPMENT 39 432 2.499e-16 6.645e-15
176 REGULATION OF DEFENSE RESPONSE 52 759 2.581e-16 6.825e-15
177 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 25 162 3.158e-16 8.301e-15
178 REGULATION OF CELL PROJECTION ORGANIZATION 44 558 4.121e-16 1.077e-14
179 NEURON DEVELOPMENT 49 687 4.227e-16 1.093e-14
180 REGULATION OF LEUKOCYTE DIFFERENTIATION 29 232 4.21e-16 1.093e-14
181 OSSIFICATION 30 251 4.473e-16 1.15e-14
182 CELL DEATH 60 1001 5.047e-16 1.29e-14
183 DEVELOPMENTAL GROWTH 34 333 5.828e-16 1.482e-14
184 RESPONSE TO STEROID HORMONE 41 497 9.534e-16 2.408e-14
185 INOSITOL LIPID MEDIATED SIGNALING 22 124 9.574e-16 2.408e-14
186 ACTIVATION OF IMMUNE RESPONSE 38 427 9.894e-16 2.475e-14
187 CYTOKINE MEDIATED SIGNALING PATHWAY 39 452 1.138e-15 2.831e-14
188 REGULATION OF APOPTOTIC SIGNALING PATHWAY 35 363 1.251e-15 3.096e-14
189 REGULATION OF GROWTH 46 633 1.83e-15 4.505e-14
190 REGULATION OF RESPONSE TO WOUNDING 37 413 1.953e-15 4.782e-14
191 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 31 289 3.028e-15 7.376e-14
192 POSITIVE REGULATION OF HEMOPOIESIS 24 163 3.746e-15 9.079e-14
193 REGULATION OF VASCULATURE DEVELOPMENT 28 233 3.833e-15 9.241e-14
194 RESPONSE TO ABIOTIC STIMULUS 59 1024 5.362e-15 1.286e-13
195 ACTIN FILAMENT BASED PROCESS 38 450 5.431e-15 1.296e-13
196 EMBRYONIC ORGAN DEVELOPMENT 36 406 6.584e-15 1.563e-13
197 CELLULAR RESPONSE TO HORMONE STIMULUS 42 552 7.021e-15 1.658e-13
198 REGULATION OF NEURON PROJECTION DEVELOPMENT 36 408 7.663e-15 1.801e-13
199 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 23 153 8.966e-15 2.096e-13
200 NEGATIVE REGULATION OF NEURON DEATH 24 171 1.129e-14 2.627e-13
201 SECRETION BY CELL 39 486 1.24e-14 2.871e-13
202 EYE DEVELOPMENT 32 326 1.332e-14 3.068e-13
203 BONE DEVELOPMENT 23 156 1.381e-14 3.164e-13
204 REGULATION OF SECRETION 47 699 1.641e-14 3.743e-13
205 PEPTIDYL AMINO ACID MODIFICATION 52 841 1.691e-14 3.839e-13
206 INNATE IMMUNE RESPONSE 44 619 1.735e-14 3.919e-13
207 POSITIVE REGULATION OF BINDING 21 127 1.895e-14 4.249e-13
208 ADAPTIVE IMMUNE RESPONSE 30 288 1.899e-14 4.249e-13
209 POSITIVE REGULATION OF TRANSPORT 55 936 2.269e-14 5.053e-13
210 HEART MORPHOGENESIS 26 212 2.325e-14 5.151e-13
211 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 22 144 2.456e-14 5.416e-13
212 RESPONSE TO PEPTIDE 35 404 3.201e-14 7.027e-13
213 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 21 131 3.596e-14 7.857e-13
214 INFLAMMATORY RESPONSE 37 454 3.835e-14 8.339e-13
215 MUSCLE ORGAN DEVELOPMENT 29 277 4.617e-14 9.992e-13
216 SKELETAL SYSTEM MORPHOGENESIS 25 201 5.365e-14 1.156e-12
217 SECRETION 42 588 6.096e-14 1.307e-12
218 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 31 323 6.476e-14 1.382e-12
219 REGULATION OF ORGAN MORPHOGENESIS 27 242 7.571e-14 1.609e-12
220 NEGATIVE REGULATION OF LOCOMOTION 28 263 8.422e-14 1.781e-12
221 PROTEIN LOCALIZATION 80 1805 8.839e-14 1.861e-12
222 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 33 372 9.224e-14 1.933e-12
223 REGULATION OF LEUKOCYTE PROLIFERATION 25 206 9.485e-14 1.979e-12
224 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 22 154 1.021e-13 2.12e-12
225 T CELL DIFFERENTIATION 20 123 1.118e-13 2.311e-12
226 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 13 39 1.225e-13 2.523e-12
227 REGULATION OF IMMUNE EFFECTOR PROCESS 35 424 1.341e-13 2.749e-12
228 RESPONSE TO MECHANICAL STIMULUS 25 210 1.479e-13 3.017e-12
229 FORMATION OF PRIMARY GERM LAYER 19 110 1.495e-13 3.037e-12
230 NEGATIVE REGULATION OF MOLECULAR FUNCTION 58 1079 1.846e-13 3.734e-12
231 RESPONSE TO INORGANIC SUBSTANCE 37 479 1.997e-13 4.022e-12
232 REGULATION OF CELLULAR LOCALIZATION 64 1277 2.084e-13 4.18e-12
233 RESPONSE TO ALCOHOL 32 362 2.453e-13 4.899e-12
234 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 46 724 2.465e-13 4.902e-12
235 LIPID PHOSPHORYLATION 18 99 2.621e-13 5.189e-12
236 CELL CHEMOTAXIS 22 162 2.951e-13 5.818e-12
237 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 15 62 3.119e-13 6.124e-12
238 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 18 100 3.143e-13 6.144e-12
239 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 35 437 3.25e-13 6.328e-12
240 REGULATION OF VESICLE MEDIATED TRANSPORT 36 462 3.324e-13 6.444e-12
241 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 24 200 3.852e-13 7.436e-12
242 REGULATION OF PEPTIDASE ACTIVITY 33 392 4.02e-13 7.728e-12
243 REGULATION OF CYTOKINE SECRETION 21 149 4.923e-13 9.427e-12
244 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 18 103 5.351e-13 1.02e-11
245 NEGATIVE REGULATION OF CELL ADHESION 25 223 5.841e-13 1.109e-11
246 RENAL TUBULE DEVELOPMENT 16 78 7.935e-13 1.501e-11
247 NEURON PROJECTION MORPHOGENESIS 33 402 8.096e-13 1.525e-11
248 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 24 207 8.226e-13 1.543e-11
249 CYTOSKELETON ORGANIZATION 49 838 8.392e-13 1.568e-11
250 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 57 1087 8.529e-13 1.587e-11
251 FOREBRAIN DEVELOPMENT 31 357 9.457e-13 1.753e-11
252 REGULATION OF ACTIN FILAMENT BASED PROCESS 29 312 9.667e-13 1.785e-11
253 REGULATION OF BODY FLUID LEVELS 37 506 1.049e-12 1.929e-11
254 PLATELET DEGRANULATION 18 107 1.058e-12 1.937e-11
255 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 25 229 1.066e-12 1.944e-11
256 RESPONSE TO DRUG 34 431 1.107e-12 2.012e-11
257 PROTEIN AUTOPHOSPHORYLATION 23 192 1.249e-12 2.262e-11
258 GLIOGENESIS 22 175 1.456e-12 2.625e-11
259 KIDNEY EPITHELIUM DEVELOPMENT 19 125 1.624e-12 2.918e-11
260 RESPONSE TO CORTICOSTEROID 22 176 1.636e-12 2.927e-11
261 MUSCLE TISSUE DEVELOPMENT 27 275 1.657e-12 2.955e-11
262 RESPONSE TO ACID CHEMICAL 29 319 1.687e-12 2.996e-11
263 REGULATION OF OSSIFICATION 22 178 2.061e-12 3.646e-11
264 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 23 197 2.152e-12 3.792e-11
265 REGULATION OF ORGANELLE ORGANIZATION 59 1178 2.18e-12 3.828e-11
266 GLAND MORPHOGENESIS 17 97 2.275e-12 3.98e-11
267 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 39 573 2.308e-12 4.023e-11
268 REGULATION OF ERK1 AND ERK2 CASCADE 25 238 2.534e-12 4.399e-11
269 REGULATION OF ENDOCYTOSIS 23 199 2.662e-12 4.604e-11
270 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 17 98 2.707e-12 4.665e-11
271 NEGATIVE REGULATION OF GENE EXPRESSION 68 1493 2.823e-12 4.848e-11
272 LEUKOCYTE HOMEOSTASIS 14 60 3.334e-12 5.703e-11
273 REGULATION OF PROTEIN COMPLEX ASSEMBLY 31 375 3.438e-12 5.859e-11
274 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 19 131 3.837e-12 6.516e-11
275 REGULATION OF EPITHELIAL CELL MIGRATION 21 166 4.192e-12 7.093e-11
276 B CELL ACTIVATION 19 132 4.408e-12 7.431e-11
277 REGULATION OF PROTEIN BINDING 21 168 5.299e-12 8.901e-11
278 POSITIVE REGULATION OF MAP KINASE ACTIVITY 23 207 6.076e-12 1.017e-10
279 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 19 135 6.631e-12 1.106e-10
280 REGULATION OF PROTEIN LOCALIZATION 51 950 6.725e-12 1.118e-10
281 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 19 136 7.579e-12 1.255e-10
282 AMEBOIDAL TYPE CELL MIGRATION 20 154 8.395e-12 1.38e-10
283 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 20 154 8.395e-12 1.38e-10
284 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 30 365 9.006e-12 1.476e-10
285 REGULATION OF CELL SUBSTRATE ADHESION 21 173 9.382e-12 1.532e-10
286 GASTRULATION 20 155 9.478e-12 1.542e-10
287 REGULATION OF NEURON APOPTOTIC PROCESS 22 192 9.55e-12 1.548e-10
288 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 22 195 1.303e-11 2.105e-10
289 NEPHRON EPITHELIUM DEVELOPMENT 16 93 1.367e-11 2.201e-10
290 REGULATION OF HOMEOSTATIC PROCESS 33 447 1.458e-11 2.339e-10
291 NEGATIVE REGULATION OF PHOSPHORYLATION 32 422 1.499e-11 2.397e-10
292 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 27 303 1.612e-11 2.568e-10
293 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 16 95 1.915e-11 3.032e-10
294 RESPONSE TO OXIDATIVE STRESS 29 352 1.915e-11 3.032e-10
295 EPITHELIAL TO MESENCHYMAL TRANSITION 13 56 2.148e-11 3.388e-10
296 RESPONSE TO OXYGEN LEVELS 27 311 2.94e-11 4.606e-10
297 HEMOSTASIS 27 311 2.94e-11 4.606e-10
298 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 16 98 3.129e-11 4.885e-10
299 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 36 541 3.237e-11 5.021e-10
300 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 36 541 3.237e-11 5.021e-10
301 REGULATION OF LYMPHOCYTE DIFFERENTIATION 18 132 4.114e-11 6.36e-10
302 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 16 100 4.296e-11 6.619e-10
303 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 13 59 4.376e-11 6.72e-10
304 REGULATION OF PROTEIN SECRETION 30 389 4.402e-11 6.738e-10
305 TELENCEPHALON DEVELOPMENT 23 228 4.449e-11 6.787e-10
306 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 18 133 4.679e-11 7.115e-10
307 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 16 101 5.02e-11 7.609e-10
308 EPITHELIAL CELL DIFFERENTIATION 34 495 5.038e-11 7.611e-10
309 MYELOID CELL DIFFERENTIATION 21 189 5.137e-11 7.735e-10
310 CHONDROCYTE DIFFERENTIATION 13 60 5.495e-11 8.247e-10
311 REGULATION OF MUSCLE CELL DIFFERENTIATION 19 152 5.543e-11 8.267e-10
312 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 19 152 5.543e-11 8.267e-10
313 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 29 368 5.606e-11 8.334e-10
314 MESODERM DEVELOPMENT 17 118 5.917e-11 8.768e-10
315 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 23 232 6.335e-11 9.357e-10
316 GLIAL CELL DIFFERENTIATION 18 136 6.836e-11 1.007e-09
317 REGULATION OF STEM CELL PROLIFERATION 15 88 6.887e-11 1.011e-09
318 REGULATION OF CYTOSKELETON ORGANIZATION 34 502 7.347e-11 1.075e-09
319 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 21 193 7.643e-11 1.115e-09
320 REGULATION OF GTPASE ACTIVITY 40 673 7.755e-11 1.128e-09
321 REGULATION OF INTERLEUKIN 6 PRODUCTION 16 104 7.923e-11 1.148e-09
322 EMBRYONIC ORGAN MORPHOGENESIS 25 279 8.255e-11 1.189e-09
323 ACTIVATION OF PROTEIN KINASE ACTIVITY 25 279 8.255e-11 1.189e-09
324 CELLULAR RESPONSE TO ACID CHEMICAL 20 175 8.936e-11 1.279e-09
325 HOMEOSTASIS OF NUMBER OF CELLS 20 175 8.936e-11 1.279e-09
326 MESONEPHROS DEVELOPMENT 15 90 9.613e-11 1.372e-09
327 POSITIVE REGULATION OF GROWTH 23 238 1.061e-10 1.505e-09
328 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 42 740 1.059e-10 1.505e-09
329 REGULATION OF PROTEOLYSIS 41 711 1.113e-10 1.574e-09
330 REGULATION OF INNATE IMMUNE RESPONSE 28 357 1.358e-10 1.915e-09
331 PLATELET ACTIVATION 18 142 1.416e-10 1.991e-09
332 REGULATION OF CHEMOTAXIS 20 180 1.491e-10 2.09e-09
333 MULTICELLULAR ORGANISM METABOLIC PROCESS 15 93 1.559e-10 2.179e-09
334 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 14 79 1.742e-10 2.426e-09
335 MESONEPHRIC TUBULE MORPHOGENESIS 12 53 1.759e-10 2.444e-09
336 ESTABLISHMENT OF PROTEIN LOCALIZATION 62 1423 1.897e-10 2.627e-09
337 REGULATED EXOCYTOSIS 22 224 1.994e-10 2.753e-09
338 REGULATION OF MYELOID CELL DIFFERENTIATION 20 183 2.011e-10 2.768e-09
339 CELL SUBSTRATE ADHESION 19 164 2.1e-10 2.882e-09
340 NEURON PROJECTION GUIDANCE 21 205 2.375e-10 3.25e-09
341 CELL JUNCTION ORGANIZATION 20 185 2.446e-10 3.337e-09
342 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 14 81 2.468e-10 3.358e-09
343 MYELOID LEUKOCYTE DIFFERENTIATION 15 96 2.484e-10 3.369e-09
344 REGULATION OF INFLAMMATORY RESPONSE 25 294 2.519e-10 3.408e-09
345 PATTERN SPECIFICATION PROCESS 30 418 2.542e-10 3.428e-09
346 CELL FATE COMMITMENT 22 227 2.578e-10 3.467e-09
347 REGULATION OF RECEPTOR BINDING 8 17 2.618e-10 3.511e-09
348 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 22 228 2.806e-10 3.752e-09
349 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 25 296 2.907e-10 3.876e-09
350 KIDNEY MORPHOGENESIS 14 82 2.927e-10 3.892e-09
351 SPROUTING ANGIOGENESIS 11 45 4.209e-10 5.579e-09
352 RESPONSE TO FIBROBLAST GROWTH FACTOR 16 116 4.244e-10 5.61e-09
353 RESPONSE TO REACTIVE OXYGEN SPECIES 20 191 4.335e-10 5.714e-09
354 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 21 213 4.834e-10 6.354e-09
355 NEGATIVE REGULATION OF TRANSPORT 31 458 5.349e-10 7.011e-09
356 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 18 156 6.758e-10 8.833e-09
357 REGULATION OF MUSCLE ORGAN DEVELOPMENT 15 103 6.896e-10 8.988e-09
358 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 15 104 7.925e-10 1.03e-08
359 REGULATION OF B CELL ACTIVATION 16 121 8.035e-10 1.039e-08
360 NEGATIVE REGULATION OF IMMUNE RESPONSE 16 121 8.035e-10 1.039e-08
361 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 12 60 8.217e-10 1.059e-08
362 REPRODUCTION 57 1297 8.42e-10 1.082e-08
363 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 11 48 8.916e-10 1.143e-08
364 HOMEOSTATIC PROCESS 58 1337 9.518e-10 1.217e-08
365 POSITIVE REGULATION OF DEFENSE RESPONSE 27 364 1.007e-09 1.284e-08
366 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 43 829 1.019e-09 1.296e-08
367 CELLULAR MACROMOLECULE LOCALIZATION 55 1234 1.052e-09 1.334e-08
368 REGULATION OF CELL GROWTH 28 391 1.081e-09 1.367e-08
369 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 11 49 1.131e-09 1.426e-08
370 LYMPHOCYTE HOMEOSTASIS 11 50 1.426e-09 1.789e-08
371 ENDODERM FORMATION 11 50 1.426e-09 1.789e-08
372 REGULATION OF WOUND HEALING 16 126 1.475e-09 1.845e-08
373 LYMPHOCYTE COSTIMULATION 13 78 1.738e-09 2.162e-08
374 RHYTHMIC PROCESS 24 298 1.734e-09 2.162e-08
375 REGULATION OF T CELL PROLIFERATION 17 147 1.956e-09 2.427e-08
376 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 13 79 2.046e-09 2.525e-08
377 BONE MORPHOGENESIS 13 79 2.046e-09 2.525e-08
378 ENDODERMAL CELL DIFFERENTIATION 10 40 2.097e-09 2.581e-08
379 POSITIVE REGULATION OF T CELL PROLIFERATION 14 95 2.191e-09 2.69e-08
380 IMMUNE EFFECTOR PROCESS 31 486 2.24e-09 2.743e-08
381 REGULATION OF AXONOGENESIS 18 168 2.263e-09 2.763e-08
382 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 23 278 2.272e-09 2.768e-08
383 REGULATION OF OSTEOBLAST DIFFERENTIATION 15 112 2.281e-09 2.771e-08
384 CELL PART MORPHOGENESIS 36 633 2.379e-09 2.883e-08
385 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 13 80 2.403e-09 2.904e-08
386 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 21 233 2.49e-09 3.002e-08
387 POSITIVE REGULATION OF PROTEIN SECRETION 20 211 2.512e-09 3.02e-08
388 OVULATION CYCLE 15 113 2.587e-09 3.102e-08
389 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 11 53 2.77e-09 3.304e-08
390 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 11 53 2.77e-09 3.304e-08
391 REPRODUCTIVE SYSTEM DEVELOPMENT 28 408 2.792e-09 3.323e-08
392 POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 16 132 2.943e-09 3.494e-08
393 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 8 22 3.177e-09 3.761e-08
394 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 15 115 3.313e-09 3.913e-08
395 MYELOID LEUKOCYTE ACTIVATION 14 98 3.327e-09 3.919e-08
396 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 10 42 3.522e-09 4.128e-08
397 CELL CELL SIGNALING 40 767 3.521e-09 4.128e-08
398 STRIATED MUSCLE CELL DIFFERENTIATION 18 173 3.628e-09 4.242e-08
399 EXOCYTOSIS 24 310 3.796e-09 4.427e-08
400 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 14 99 3.811e-09 4.433e-08
401 ORGAN REGENERATION 13 83 3.837e-09 4.452e-08
402 CRANIAL SKELETAL SYSTEM DEVELOPMENT 11 55 4.206e-09 4.869e-08
403 SALIVARY GLAND DEVELOPMENT 9 32 4.335e-09 4.993e-08
404 ENDOCARDIAL CUSHION DEVELOPMENT 9 32 4.335e-09 4.993e-08
405 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 18 175 4.362e-09 5.012e-08
406 RESPONSE TO ESTROGEN 20 218 4.424e-09 5.07e-08
407 REGULATION OF DEVELOPMENTAL GROWTH 23 289 4.784e-09 5.466e-08
408 REGULATION OF METANEPHROS DEVELOPMENT 8 23 4.793e-09 5.466e-08
409 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 17 156 4.894e-09 5.568e-08
410 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 14 101 4.976e-09 5.647e-08
411 SMAD PROTEIN SIGNAL TRANSDUCTION 11 56 5.149e-09 5.829e-08
412 PALATE DEVELOPMENT 13 85 5.184e-09 5.854e-08
413 NEGATIVE REGULATION OF CELL CELL ADHESION 16 138 5.659e-09 6.375e-08
414 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 10 44 5.748e-09 6.46e-08
415 NEGATIVE REGULATION OF CELL ACTIVATION 17 158 5.947e-09 6.652e-08
416 RESPONSE TO PURINE CONTAINING COMPOUND 17 158 5.947e-09 6.652e-08
417 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 61 1517 6.012e-09 6.68e-08
418 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 13 86 6.006e-09 6.68e-08
419 POSITIVE REGULATION OF CHEMOTAXIS 15 120 6.015e-09 6.68e-08
420 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 11 57 6.276e-09 6.934e-08
421 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 16 139 6.289e-09 6.934e-08
422 ENDODERM DEVELOPMENT 12 71 6.265e-09 6.934e-08
423 REGULATION OF MUSCLE TISSUE DEVELOPMENT 14 103 6.456e-09 7.101e-08
424 REGULATION OF PROTEIN KINASE B SIGNALING 15 121 6.753e-09 7.41e-08
425 EXOCRINE SYSTEM DEVELOPMENT 10 45 7.27e-09 7.959e-08
426 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 15 122 7.572e-09 8.27e-08
427 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 34 7.846e-09 8.53e-08
428 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 9 34 7.846e-09 8.53e-08
429 LEUKOCYTE PROLIFERATION 13 88 8.014e-09 8.693e-08
430 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 34 602 8.077e-09 8.74e-08
431 ODONTOGENESIS 14 105 8.326e-09 8.988e-08
432 POSITIVE REGULATION OF PROTEIN BINDING 12 73 8.704e-09 9.375e-08
433 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 10 46 9.138e-09 9.797e-08
434 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 10 46 9.138e-09 9.797e-08
435 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 11 60 1.109e-08 1.187e-07
436 NEURAL CREST CELL DIFFERENTIATION 12 75 1.196e-08 1.277e-07
437 NUCLEAR TRANSPORT 25 355 1.213e-08 1.292e-07
438 LIPID MODIFICATION 19 210 1.36e-08 1.443e-07
439 RESPONSE TO HYDROGEN PEROXIDE 14 109 1.361e-08 1.443e-07
440 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 34 616 1.428e-08 1.51e-07
441 RESPONSE TO CARBOHYDRATE 17 168 1.509e-08 1.592e-07
442 RESPONSE TO METAL ION 24 333 1.533e-08 1.614e-07
443 DIGESTIVE SYSTEM DEVELOPMENT 16 148 1.562e-08 1.641e-07
444 REGULATION OF INTRACELLULAR TRANSPORT 34 621 1.742e-08 1.825e-07
445 GLOMERULUS DEVELOPMENT 10 49 1.754e-08 1.834e-07
446 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 36 684 1.785e-08 1.862e-07
447 MUSCLE CELL DIFFERENTIATION 20 237 1.842e-08 1.918e-07
448 REGULATION OF CARTILAGE DEVELOPMENT 11 63 1.897e-08 1.971e-07
449 REGIONALIZATION 23 311 1.908e-08 1.977e-07
450 REGULATION OF CELLULAR COMPONENT SIZE 24 337 1.93e-08 1.995e-07
451 RESPONSE TO AMINO ACID 14 112 1.94e-08 2.002e-07
452 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 21 262 1.998e-08 2.056e-07
453 NEGATIVE REGULATION OF BINDING 15 131 2.02e-08 2.075e-07
454 DEVELOPMENTAL MATURATION 18 193 2.051e-08 2.102e-07
455 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 17 172 2.148e-08 2.196e-07
456 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 10 50 2.157e-08 2.201e-07
457 COLLAGEN FIBRIL ORGANIZATION 9 38 2.285e-08 2.321e-07
458 MESENCHYME MORPHOGENESIS 9 38 2.285e-08 2.321e-07
459 REGULATION OF CELLULAR RESPONSE TO STRESS 36 691 2.313e-08 2.345e-07
460 POSITIVE REGULATION OF CYTOKINE SECRETION 13 96 2.359e-08 2.381e-07
461 CARDIOCYTE DIFFERENTIATION 13 96 2.359e-08 2.381e-07
462 EAR DEVELOPMENT 18 195 2.408e-08 2.425e-07
463 POSITIVE REGULATION OF ENDOCYTOSIS 14 114 2.442e-08 2.454e-07
464 REGULATION OF CYTOPLASMIC TRANSPORT 29 481 2.612e-08 2.619e-07
465 ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS 16 154 2.761e-08 2.763e-07
466 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 12 81 2.933e-08 2.928e-07
467 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 8 29 3.808e-08 3.786e-07
468 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 29 3.808e-08 3.786e-07
469 REGULATION OF ION HOMEOSTASIS 18 201 3.852e-08 3.822e-07
470 REGULATION OF LIPASE ACTIVITY 12 83 3.886e-08 3.847e-07
471 REGULATION OF METAL ION TRANSPORT 23 325 4.307e-08 4.255e-07
472 CELLULAR RESPONSE TO PEPTIDE 21 274 4.34e-08 4.279e-07
473 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 11 68 4.35e-08 4.279e-07
474 TISSUE MIGRATION 12 84 4.459e-08 4.368e-07
475 POSITIVE REGULATION OF OSSIFICATION 12 84 4.459e-08 4.368e-07
476 CELLULAR RESPONSE TO STRESS 60 1565 4.593e-08 4.49e-07
477 B CELL RECEPTOR SIGNALING PATHWAY 10 54 4.705e-08 4.59e-07
478 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 13 102 4.948e-08 4.816e-07
479 CARDIAC MUSCLE TISSUE DEVELOPMENT 15 140 4.979e-08 4.837e-07
480 POSITIVE REGULATION OF AXONOGENESIS 11 69 5.09e-08 4.934e-07
481 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 14 121 5.262e-08 5.09e-07
482 NEGATIVE REGULATION OF CELL DEVELOPMENT 22 303 5.416e-08 5.228e-07
483 GLYCEROLIPID METABOLIC PROCESS 24 356 5.476e-08 5.275e-07
484 ACTIN CYTOSKELETON REORGANIZATION 10 55 5.657e-08 5.439e-07
485 CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS 6 13 5.827e-08 5.579e-07
486 RESPONSE TO HEPATOCYTE GROWTH FACTOR 6 13 5.827e-08 5.579e-07
487 CELLULAR RESPONSE TO OXIDATIVE STRESS 17 184 5.841e-08 5.581e-07
488 REGULATION OF HEART GROWTH 9 42 5.856e-08 5.583e-07
489 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 11 70 5.94e-08 5.652e-07
490 RESPONSE TO CAMP 13 104 6.26e-08 5.944e-07
491 REGULATION OF ANATOMICAL STRUCTURE SIZE 28 472 6.434e-08 6.097e-07
492 REGULATION OF ADAPTIVE IMMUNE RESPONSE 14 123 6.488e-08 6.136e-07
493 REGULATION OF COAGULATION 12 88 7.585e-08 7.159e-07
494 SYSTEM PROCESS 65 1785 7.914e-08 7.455e-07
495 ENDOTHELIAL CELL MIGRATION 10 57 8.083e-08 7.598e-07
496 INTERSPECIES INTERACTION BETWEEN ORGANISMS 34 662 8.169e-08 7.648e-07
497 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 34 662 8.169e-08 7.648e-07
498 PHOSPHOLIPID METABOLIC PROCESS 24 364 8.307e-08 7.762e-07
499 IN UTERO EMBRYONIC DEVELOPMENT 22 311 8.575e-08 7.996e-07
500 B CELL DIFFERENTIATION 12 89 8.623e-08 8.025e-07
501 T CELL RECEPTOR SIGNALING PATHWAY 15 146 8.739e-08 8.116e-07
502 REGULATION OF SEQUESTERING OF CALCIUM ION 13 107 8.819e-08 8.158e-07
503 REGULATION OF T CELL DIFFERENTIATION 13 107 8.819e-08 8.158e-07
504 NEGATIVE REGULATION OF ION TRANSPORT 14 127 9.743e-08 8.995e-07
505 REGULATION OF DNA METABOLIC PROCESS 23 340 9.797e-08 9.009e-07
506 REGULATION OF CELL MATRIX ADHESION 12 90 9.787e-08 9.009e-07
507 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 6 14 1.004e-07 9.213e-07
508 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 11 74 1.074e-07 9.821e-07
509 CARDIAC MUSCLE CELL DIFFERENTIATION 11 74 1.074e-07 9.821e-07
510 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 29 514 1.088e-07 9.926e-07
511 POSITIVE REGULATION OF SECRETION 24 370 1.126e-07 1.026e-06
512 CHEMICAL HOMEOSTASIS 40 874 1.25e-07 1.136e-06
513 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 12 93 1.416e-07 1.285e-06
514 EXTRACELLULAR MATRIX DISASSEMBLY 11 76 1.424e-07 1.289e-06
515 RESPONSE TO FLUID SHEAR STRESS 8 34 1.486e-07 1.343e-06
516 ZYMOGEN ACTIVATION 13 112 1.522e-07 1.373e-06
517 VESICLE MEDIATED TRANSPORT 50 1239 1.538e-07 1.384e-06
518 RESPIRATORY SYSTEM DEVELOPMENT 17 197 1.58e-07 1.417e-06
519 POSITIVE REGULATION OF STEM CELL PROLIFERATION 10 61 1.581e-07 1.417e-06
520 POSITIVE REGULATION OF CELL DIVISION 14 132 1.585e-07 1.418e-06
521 PALLIUM DEVELOPMENT 15 153 1.626e-07 1.452e-06
522 REGULATION OF STEM CELL DIFFERENTIATION 13 113 1.692e-07 1.508e-06
523 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 21 297 1.706e-07 1.515e-06
524 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 19 246 1.705e-07 1.515e-06
525 CELL CYCLE ARREST 15 154 1.772e-07 1.57e-06
526 REGULATION OF CELL DIVISION 20 272 1.795e-07 1.588e-06
527 POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 7 24 1.816e-07 1.6e-06
528 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 7 24 1.816e-07 1.6e-06
529 REGULATION OF ENDOTHELIAL CELL MIGRATION 13 114 1.878e-07 1.652e-06
530 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 9 48 1.998e-07 1.754e-06
531 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 20 274 2.02e-07 1.77e-06
532 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 15 156 2.099e-07 1.829e-06
533 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 15 156 2.099e-07 1.829e-06
534 CELL GROWTH 14 135 2.099e-07 1.829e-06
535 ERBB SIGNALING PATHWAY 11 79 2.139e-07 1.86e-06
536 RESPONSE TO EXTRACELLULAR STIMULUS 26 441 2.171e-07 1.884e-06
537 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 16 179 2.266e-07 1.964e-06
538 POSITIVE CHEMOTAXIS 8 36 2.399e-07 2.071e-06
539 HEAD MORPHOGENESIS 8 36 2.399e-07 2.071e-06
540 REGULATION OF PHOSPHOLIPASE ACTIVITY 10 64 2.528e-07 2.179e-06
541 LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 12 98 2.543e-07 2.187e-06
542 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 6 16 2.595e-07 2.227e-06
543 REGULATION OF FIBROBLAST PROLIFERATION 11 81 2.777e-07 2.38e-06
544 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 13 118 2.822e-07 2.414e-06
545 FACE DEVELOPMENT 9 50 2.889e-07 2.466e-06
546 REGULATION OF CHEMOKINE PRODUCTION 10 65 2.939e-07 2.5e-06
547 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 10 65 2.939e-07 2.5e-06
548 RESPONSE TO ORGANOPHOSPHORUS 14 139 3.018e-07 2.563e-06
549 RECEPTOR METABOLIC PROCESS 11 82 3.155e-07 2.664e-06
550 POSITIVE REGULATION OF PROTEOLYSIS 23 363 3.152e-07 2.664e-06
551 INTEGRIN MEDIATED SIGNALING PATHWAY 11 82 3.155e-07 2.664e-06
552 MESODERM MORPHOGENESIS 10 66 3.408e-07 2.873e-06
553 NEURAL CREST CELL MIGRATION 9 51 3.451e-07 2.904e-06
554 REGULATION OF WNT SIGNALING PATHWAY 21 310 3.479e-07 2.922e-06
555 POSITIVE REGULATION OF DNA METABOLIC PROCESS 16 185 3.556e-07 2.981e-06
556 REGULATION OF CALCIUM ION TRANSPORT 17 209 3.682e-07 3.082e-06
557 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 10 67 3.941e-07 3.286e-06
558 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 10 67 3.941e-07 3.286e-06
559 REGULATION OF CELL CYCLE 41 949 3.961e-07 3.297e-06
560 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 10 68 4.546e-07 3.757e-06
561 REGULATION OF CELL JUNCTION ASSEMBLY 10 68 4.546e-07 3.757e-06
562 NERVE DEVELOPMENT 10 68 4.546e-07 3.757e-06
563 POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 10 68 4.546e-07 3.757e-06
564 REGULATION OF PHOSPHOLIPASE C ACTIVITY 8 39 4.647e-07 3.82e-06
565 TRABECULA MORPHOGENESIS 8 39 4.647e-07 3.82e-06
566 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 8 39 4.647e-07 3.82e-06
567 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 14 144 4.667e-07 3.83e-06
568 CELLULAR RESPONSE TO AMINO ACID STIMULUS 9 53 4.867e-07 3.987e-06
569 CELLULAR RESPONSE TO EXTERNAL STIMULUS 19 264 5.069e-07 4.146e-06
570 SENSORY ORGAN MORPHOGENESIS 18 239 5.23e-07 4.262e-06
571 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 10 69 5.23e-07 4.262e-06
572 RESPONSE TO ESTRADIOL 14 146 5.527e-07 4.496e-06
573 POSITIVE REGULATION OF CELL MATRIX ADHESION 8 40 5.716e-07 4.641e-06
574 TISSUE REMODELING 11 87 5.811e-07 4.711e-06
575 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 6 18 5.829e-07 4.717e-06
576 PROTEIN COMPLEX SUBUNIT ORGANIZATION 56 1527 5.856e-07 4.731e-06
577 OSTEOBLAST DIFFERENTIATION 13 126 6.065e-07 4.891e-06
578 REGULATION OF ION TRANSPORT 30 592 6.473e-07 5.211e-06
579 POSITIVE REGULATION OF CELL GROWTH 14 148 6.526e-07 5.241e-06
580 OVULATION CYCLE PROCESS 11 88 6.533e-07 5.241e-06
581 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 17 218 6.673e-07 5.345e-06
582 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 9 55 6.759e-07 5.395e-06
583 REGULATION OF KIDNEY DEVELOPMENT 9 55 6.759e-07 5.395e-06
584 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 15 171 6.898e-07 5.496e-06
585 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 8 41 6.988e-07 5.558e-06
586 MUSCLE CELL DEVELOPMENT 13 128 7.275e-07 5.777e-06
587 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 12 108 7.4e-07 5.865e-06
588 REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS 7 29 7.563e-07 5.985e-06
589 OUTFLOW TRACT MORPHOGENESIS 9 56 7.924e-07 6.26e-06
590 REGULATION OF CATABOLIC PROCESS 34 731 8.128e-07 6.41e-06
591 FIBRIL ORGANIZATION 6 19 8.388e-07 6.57e-06
592 DETECTION OF OTHER ORGANISM 6 19 8.388e-07 6.57e-06
593 KIDNEY VASCULATURE DEVELOPMENT 6 19 8.388e-07 6.57e-06
594 RENAL SYSTEM VASCULATURE DEVELOPMENT 6 19 8.388e-07 6.57e-06
595 ACTIN FILAMENT ORGANIZATION 15 174 8.614e-07 6.736e-06
596 REGULATION OF CHRONIC INFLAMMATORY RESPONSE 5 11 8.775e-07 6.85e-06
597 MULTICELLULAR ORGANISM REPRODUCTION 35 768 8.886e-07 6.926e-06
598 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 10 73 8.951e-07 6.93e-06
599 POSITIVE REGULATION OF STAT CASCADE 10 73 8.951e-07 6.93e-06
600 POSITIVE REGULATION OF JAK STAT CASCADE 10 73 8.951e-07 6.93e-06
601 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 10 73 8.951e-07 6.93e-06
602 REGULATION OF SYSTEM PROCESS 27 507 9.317e-07 7.202e-06
603 RETINA DEVELOPMENT IN CAMERA TYPE EYE 13 131 9.496e-07 7.327e-06
604 NEGATIVE REGULATION OF B CELL ACTIVATION 7 30 9.709e-07 7.479e-06
605 NEGATIVE REGULATION OF KINASE ACTIVITY 18 250 1.007e-06 7.746e-06
606 NEGATIVE REGULATION OF SECRETION 16 200 1.014e-06 7.789e-06
607 REGULATION OF DNA BINDING 11 93 1.146e-06 8.786e-06
608 BODY MORPHOGENESIS 8 44 1.235e-06 9.39e-06
609 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 7 31 1.234e-06 9.39e-06
610 LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 7 31 1.234e-06 9.39e-06
611 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 14 156 1.235e-06 9.39e-06
612 NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 8 44 1.235e-06 9.39e-06
613 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 11 94 1.277e-06 9.661e-06
614 RESPONSE TO BMP 11 94 1.277e-06 9.661e-06
615 CELLULAR RESPONSE TO BMP STIMULUS 11 94 1.277e-06 9.661e-06
616 REGULATION OF CALCIUM MEDIATED SIGNALING 10 76 1.309e-06 9.89e-06
617 REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 12 114 1.327e-06 1.001e-05
618 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 19 282 1.371e-06 1.032e-05
619 RESPONSE TO INSULIN 16 205 1.407e-06 1.058e-05
620 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 11 95 1.421e-06 1.066e-05
621 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 9 60 1.449e-06 1.086e-05
622 ACTOMYOSIN STRUCTURE ORGANIZATION 10 77 1.48e-06 1.106e-05
623 NEGATIVE REGULATION OF RECEPTOR BINDING 5 12 1.481e-06 1.106e-05
624 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 23 397 1.486e-06 1.108e-05
625 FC RECEPTOR SIGNALING PATHWAY 16 206 1.5e-06 1.117e-05
626 REGULATION OF CELLULAR PROTEIN LOCALIZATION 28 552 1.518e-06 1.128e-05
627 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 7 32 1.555e-06 1.152e-05
628 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 7 32 1.555e-06 1.152e-05
629 FEMALE SEX DIFFERENTIATION 12 116 1.599e-06 1.183e-05
630 B CELL HOMEOSTASIS 6 21 1.626e-06 1.201e-05
631 REGULATION OF INTERFERON GAMMA PRODUCTION 11 97 1.751e-06 1.29e-05
632 MAMMARY GLAND DEVELOPMENT 12 117 1.753e-06 1.29e-05
633 REGULATION OF INTERLEUKIN 10 PRODUCTION 8 46 1.761e-06 1.294e-05
634 NEGATIVE REGULATION OF PROTEIN BINDING 10 79 1.882e-06 1.381e-05
635 DENDRITIC CELL DIFFERENTIATION 7 33 1.943e-06 1.421e-05
636 NEURON PROJECTION REGENERATION 7 33 1.943e-06 1.421e-05
637 EPITHELIAL CELL DEVELOPMENT 15 186 1.998e-06 1.46e-05
638 SKIN DEVELOPMENT 16 211 2.055e-06 1.499e-05
639 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 8 47 2.088e-06 1.521e-05
640 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 10 80 2.115e-06 1.538e-05
641 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 11 99 2.147e-06 1.559e-05
642 ENDOCARDIAL CUSHION MORPHOGENESIS 6 22 2.201e-06 1.595e-05
643 REGULATION OF CELL KILLING 9 63 2.21e-06 1.599e-05
644 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 15 188 2.284e-06 1.65e-05
645 CYTOKINE PRODUCTION 12 120 2.295e-06 1.655e-05
646 METANEPHROS DEVELOPMENT 10 81 2.374e-06 1.705e-05
647 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 5 13 2.371e-06 1.705e-05
648 EXTRACELLULAR FIBRIL ORGANIZATION 5 13 2.371e-06 1.705e-05
649 REGULATION OF MESENCHYMAL CELL PROLIFERATION 7 34 2.408e-06 1.721e-05
650 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 7 34 2.408e-06 1.721e-05
651 HEART VALVE DEVELOPMENT 7 34 2.408e-06 1.721e-05
652 REGULATION OF MULTI ORGANISM PROCESS 25 470 2.428e-06 1.733e-05
653 LEUKOCYTE MEDIATED IMMUNITY 15 189 2.44e-06 1.738e-05
654 MYOFIBRIL ASSEMBLY 8 48 2.466e-06 1.754e-05
655 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 12 122 2.733e-06 1.942e-05
656 REGULATION OF JAK STAT CASCADE 13 144 2.774e-06 1.961e-05
657 RESPONSE TO INTERFERON GAMMA 13 144 2.774e-06 1.961e-05
658 REGULATION OF STAT CASCADE 13 144 2.774e-06 1.961e-05
659 CELLULAR CHEMICAL HOMEOSTASIS 28 570 2.817e-06 1.989e-05
660 PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 9 65 2.889e-06 2.034e-05
661 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 11 102 2.889e-06 2.034e-05
662 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 8 49 2.9e-06 2.035e-05
663 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 8 49 2.9e-06 2.035e-05
664 TRABECULA FORMATION 6 23 2.932e-06 2.054e-05
665 NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 7 35 2.962e-06 2.073e-05
666 REGULATION OF CALCIUM ION IMPORT 11 103 3.182e-06 2.223e-05
667 FOREBRAIN GENERATION OF NEURONS 9 66 3.292e-06 2.293e-05
668 POSITIVE REGULATION OF LIPASE ACTIVITY 9 66 3.292e-06 2.293e-05
669 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 10 84 3.323e-06 2.309e-05
670 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 17 245 3.325e-06 2.309e-05
671 STAT CASCADE 8 50 3.397e-06 2.352e-05
672 JAK STAT CASCADE 8 50 3.397e-06 2.352e-05
673 CARDIAC CHAMBER MORPHOGENESIS 11 104 3.5e-06 2.416e-05
674 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 11 104 3.5e-06 2.416e-05
675 TOXIN TRANSPORT 7 36 3.619e-06 2.495e-05
676 CRANIOFACIAL SUTURE MORPHOGENESIS 5 14 3.632e-06 2.497e-05
677 REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 14 3.632e-06 2.497e-05
678 RESPONSE TO VIRUS 17 247 3.71e-06 2.542e-05
679 POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 10 85 3.705e-06 2.542e-05
680 PEPTIDYL SERINE MODIFICATION 13 148 3.764e-06 2.576e-05
681 AXON REGENERATION 6 24 3.849e-06 2.622e-05
682 POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 6 24 3.849e-06 2.622e-05
683 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 12 126 3.838e-06 2.622e-05
684 REGULATION OF CELL SIZE 14 172 3.933e-06 2.675e-05
685 ARTERY MORPHOGENESIS 8 51 3.965e-06 2.686e-05
686 REGULATION OF INTERLEUKIN 12 PRODUCTION 8 51 3.965e-06 2.686e-05
687 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 8 51 3.965e-06 2.686e-05
688 REGULATION OF LEUKOCYTE MIGRATION 13 149 4.057e-06 2.744e-05
689 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 15 197 4.073e-06 2.75e-05
690 REGULATION OF PROTEIN POLYMERIZATION 14 173 4.209e-06 2.838e-05
691 REGULATION OF FAT CELL DIFFERENTIATION 11 106 4.221e-06 2.843e-05
692 REGULATION OF ALPHA BETA T CELL ACTIVATION 9 68 4.243e-06 2.853e-05
693 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 7 37 4.393e-06 2.946e-05
694 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 7 37 4.393e-06 2.946e-05
695 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 12 128 4.525e-06 3.03e-05
696 TISSUE REGENERATION 8 52 4.612e-06 3.083e-05
697 POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 9 69 4.8e-06 3.2e-05
698 NEGATIVE REGULATION OF OSSIFICATION 9 69 4.8e-06 3.2e-05
699 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 12 129 4.908e-06 3.262e-05
700 CELL JUNCTION ASSEMBLY 12 129 4.908e-06 3.262e-05
701 CIRCULATORY SYSTEM PROCESS 21 366 4.953e-06 3.288e-05
702 CELLULAR EXTRAVASATION 6 25 4.985e-06 3.304e-05
703 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 10 88 5.089e-06 3.364e-05
704 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 10 88 5.089e-06 3.364e-05
705 POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING 7 38 5.301e-06 3.494e-05
706 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 7 38 5.301e-06 3.494e-05
707 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 8 53 5.345e-06 3.518e-05
708 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 5 15 5.366e-06 3.522e-05
709 JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY 5 15 5.366e-06 3.522e-05
710 PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 11 109 5.547e-06 3.635e-05
711 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 8 54 6.174e-06 4.041e-05
712 REGULATION OF OXIDOREDUCTASE ACTIVITY 10 90 6.243e-06 4.068e-05
713 ENDOTHELIUM DEVELOPMENT 10 90 6.243e-06 4.068e-05
714 ACTIVATION OF INNATE IMMUNE RESPONSE 15 204 6.239e-06 4.068e-05
715 ERBB2 SIGNALING PATHWAY 7 39 6.359e-06 4.121e-05
716 ANATOMICAL STRUCTURE MATURATION 7 39 6.359e-06 4.121e-05
717 ASTROCYTE DIFFERENTIATION 7 39 6.359e-06 4.121e-05
718 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 7 39 6.359e-06 4.121e-05
719 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 6 26 6.381e-06 4.129e-05
720 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 11 111 6.62e-06 4.278e-05
721 PROTEIN LOCALIZATION TO NUCLEUS 13 156 6.727e-06 4.341e-05
722 ENDOTHELIAL CELL DIFFERENTIATION 9 72 6.867e-06 4.426e-05
723 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 55 7.11e-06 4.576e-05
724 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 7 40 7.586e-06 4.869e-05
725 RESPONSE TO KETONE 14 182 7.578e-06 4.869e-05
726 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 10 92 7.616e-06 4.881e-05
727 CARDIAC MYOFIBRIL ASSEMBLY 5 16 7.687e-06 4.913e-05
728 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 5 16 7.687e-06 4.913e-05
729 REGULATION OF ORGAN GROWTH 9 73 7.707e-06 4.919e-05
730 POSITIVE REGULATION OF HEART GROWTH 6 27 8.077e-06 5.127e-05
731 DETECTION OF BIOTIC STIMULUS 6 27 8.077e-06 5.127e-05
732 REGULATION OF PROTEIN IMPORT 14 183 8.07e-06 5.127e-05
733 NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 6 27 8.077e-06 5.127e-05
734 EYE MORPHOGENESIS 12 136 8.479e-06 5.375e-05
735 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 14 184 8.591e-06 5.439e-05
736 NEGATIVE REGULATION OF GROWTH 16 236 8.656e-06 5.472e-05
737 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 7 41 9.004e-06 5.677e-05
738 REGULATION OF B CELL MEDIATED IMMUNITY 7 41 9.004e-06 5.677e-05
739 SKELETAL MUSCLE ORGAN DEVELOPMENT 12 137 9.141e-06 5.747e-05
740 ACTIVATION OF MAPK ACTIVITY 12 137 9.141e-06 5.747e-05
741 RESPONSE TO INTERLEUKIN 1 11 115 9.321e-06 5.829e-05
742 CELLULAR RESPONSE TO ALCOHOL 11 115 9.321e-06 5.829e-05
743 CELLULAR HOMEOSTASIS 30 676 9.29e-06 5.829e-05
744 RESPONSE TO CALCIUM ION 11 115 9.321e-06 5.829e-05
745 POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 8 57 9.345e-06 5.837e-05
746 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 9 75 9.653e-06 6.021e-05
747 ENDOCYTOSIS 25 509 9.733e-06 6.063e-05
748 SEX DIFFERENTIATION 17 266 9.92e-06 6.171e-05
749 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 6 28 1.012e-05 6.287e-05
750 MULTI MULTICELLULAR ORGANISM PROCESS 15 213 1.05e-05 6.515e-05
751 REGULATION OF CELL SHAPE 12 139 1.06e-05 6.569e-05
752 POSITIVE REGULATION OF DNA BINDING 7 42 1.064e-05 6.572e-05
753 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 7 42 1.064e-05 6.572e-05
754 LEUKOCYTE CHEMOTAXIS 11 117 1.1e-05 6.788e-05
755 PHAGOCYTOSIS 14 190 1.239e-05 7.636e-05
756 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 15 216 1.241e-05 7.638e-05
757 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 7 43 1.25e-05 7.686e-05
758 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 6 29 1.256e-05 7.712e-05
759 NEGATIVE REGULATION OF PROTEOLYSIS 19 329 1.278e-05 7.833e-05
760 CELL MATRIX ADHESION 11 119 1.293e-05 7.919e-05
761 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 14 191 1.315e-05 8.04e-05
762 STEM CELL PROLIFERATION 8 60 1.379e-05 8.421e-05
763 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 15 218 1.385e-05 8.445e-05
764 POSITIVE REGULATION OF CELL CYCLE 19 332 1.451e-05 8.836e-05
765 RETINAL GANGLION CELL AXON GUIDANCE 5 18 1.463e-05 8.885e-05
766 ORGAN MATURATION 5 18 1.463e-05 8.885e-05
767 DENDRITE DEVELOPMENT 9 79 1.483e-05 8.995e-05
768 CARDIAC CHAMBER DEVELOPMENT 12 144 1.518e-05 9.199e-05
769 ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY 6 30 1.546e-05 9.319e-05
770 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 6 30 1.546e-05 9.319e-05
771 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 6 30 1.546e-05 9.319e-05
772 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 6 30 1.546e-05 9.319e-05
773 REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 8 61 1.562e-05 9.402e-05
774 PEPTIDYL TYROSINE DEPHOSPHORYLATION 10 100 1.605e-05 9.647e-05
775 SYNAPSE ORGANIZATION 12 145 1.628e-05 9.751e-05
776 NEGATIVE REGULATION OF MAPK CASCADE 12 145 1.628e-05 9.751e-05
777 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 12 145 1.628e-05 9.751e-05
778 CELLULAR RESPONSE TO INTERFERON GAMMA 11 122 1.639e-05 9.802e-05
779 ALPHA BETA T CELL DIFFERENTIATION 7 45 1.706e-05 0.0001014
780 GLUCOSE HOMEOSTASIS 13 170 1.704e-05 0.0001014
781 CARBOHYDRATE HOMEOSTASIS 13 170 1.704e-05 0.0001014
782 ENDOCHONDRAL BONE MORPHOGENESIS 7 45 1.706e-05 0.0001014
783 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 7 45 1.706e-05 0.0001014
784 ENDOCRINE SYSTEM DEVELOPMENT 11 123 1.771e-05 0.0001051
785 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 10 102 1.911e-05 0.0001133
786 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 5 19 1.955e-05 0.0001156
787 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 5 19 1.955e-05 0.0001156
788 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 20 370 1.981e-05 0.0001166
789 REGULATION OF CHONDROCYTE DIFFERENTIATION 7 46 1.981e-05 0.0001166
790 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 7 46 1.981e-05 0.0001166
791 NEGATIVE REGULATION OF CYTOKINE SECRETION 7 46 1.981e-05 0.0001166
792 NEGATIVE REGULATION OF CELL CYCLE 22 433 1.998e-05 0.0001174
793 REGULATION OF PROTEIN MATURATION 9 82 2.011e-05 0.000118
794 REGULATION OF LIPID METABOLIC PROCESS 17 282 2.113e-05 0.0001238
795 REGULATION OF ERBB SIGNALING PATHWAY 9 83 2.22e-05 0.0001299
796 POSITIVE REGULATION OF PROTEIN IMPORT 10 104 2.267e-05 0.0001325
797 REGULATION OF IMMUNOGLOBULIN PRODUCTION 7 47 2.291e-05 0.0001332
798 PATTERNING OF BLOOD VESSELS 6 32 2.287e-05 0.0001332
799 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 6 32 2.287e-05 0.0001332
800 POSITIVE REGULATION OF DEPHOSPHORYLATION 7 47 2.291e-05 0.0001332
801 INTRACELLULAR PROTEIN TRANSPORT 32 781 2.302e-05 0.0001337
802 CEREBRAL CORTEX DEVELOPMENT 10 105 2.465e-05 0.000143
803 CELLULAR RESPONSE TO RETINOIC ACID 8 65 2.511e-05 0.0001455
804 CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 5 20 2.568e-05 0.0001484
805 RESPONSE TO PROTOZOAN 5 20 2.568e-05 0.0001484
806 NEGATIVE REGULATION OF CATABOLIC PROCESS 14 203 2.605e-05 0.0001504
807 RESPONSE TO AXON INJURY 7 48 2.64e-05 0.000152
808 REGULATION OF LIPID KINASE ACTIVITY 7 48 2.64e-05 0.000152
809 SINGLE ORGANISM CELLULAR LOCALIZATION 35 898 2.682e-05 0.0001543
810 REGULATION OF REPRODUCTIVE PROCESS 11 129 2.77e-05 0.0001589
811 NUCLEAR IMPORT 11 129 2.77e-05 0.0001589
812 APOPTOTIC SIGNALING PATHWAY 17 289 2.887e-05 0.0001655
813 RESPONSE TO RETINOIC ACID 10 107 2.906e-05 0.0001663
814 POSITIVE REGULATION OF DNA REPLICATION 9 86 2.958e-05 0.0001689
815 POSITIVE REGULATION OF B CELL ACTIVATION 9 86 2.958e-05 0.0001689
816 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 19 351 3.129e-05 0.0001784
817 CELL AGING 8 67 3.142e-05 0.0001787
818 NEURON FATE COMMITMENT 8 67 3.142e-05 0.0001787
819 PROTEIN IMPORT 12 155 3.171e-05 0.0001802
820 CELL MATURATION 11 131 3.197e-05 0.0001814
821 T CELL HOMEOSTASIS 6 34 3.291e-05 0.0001865
822 REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 5 21 3.319e-05 0.0001879
823 REGULATION OF ACTIN FILAMENT LENGTH 12 156 3.38e-05 0.0001911
824 POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 11 3.395e-05 0.0001915
825 DETECTION OF MOLECULE OF BACTERIAL ORIGIN 4 11 3.395e-05 0.0001915
826 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 10 109 3.413e-05 0.0001921
827 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 14 208 3.409e-05 0.0001921
828 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 7 50 3.469e-05 0.000195
829 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 15 236 3.508e-05 0.0001969
830 CELLULAR RESPONSE TO INTERLEUKIN 1 9 88 3.559e-05 0.0001995
831 PROTEIN MATURATION 16 265 3.615e-05 0.0002024
832 NEURON MIGRATION 10 110 3.694e-05 0.0002066
833 NEGATIVE REGULATION OF PROTEIN PROCESSING 6 35 3.91e-05 0.0002166
834 NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION 8 69 3.901e-05 0.0002166
835 RESPONSE TO HEAT 9 89 3.895e-05 0.0002166
836 NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 6 35 3.91e-05 0.0002166
837 POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION 8 69 3.901e-05 0.0002166
838 POSITIVE REGULATION OF PROTEIN POLYMERIZATION 9 89 3.895e-05 0.0002166
839 NEGATIVE REGULATION OF PROTEIN MATURATION 6 35 3.91e-05 0.0002166
840 B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 6 35 3.91e-05 0.0002166
841 ESTABLISHMENT OF LOCALIZATION IN CELL 54 1676 3.995e-05 0.000221
842 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 22 4.231e-05 0.0002335
843 AORTA MORPHOGENESIS 5 22 4.231e-05 0.0002335
844 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 19 360 4.409e-05 0.0002431
845 NEUROMUSCULAR JUNCTION DEVELOPMENT 6 36 4.62e-05 0.0002523
846 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 36 4.62e-05 0.0002523
847 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 6 36 4.62e-05 0.0002523
848 POSITIVE REGULATION OF AXON EXTENSION 6 36 4.62e-05 0.0002523
849 REGULATION OF ERYTHROCYTE DIFFERENTIATION 6 36 4.62e-05 0.0002523
850 OLFACTORY LOBE DEVELOPMENT 6 36 4.62e-05 0.0002523
851 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 6 36 4.62e-05 0.0002523
852 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 6 36 4.62e-05 0.0002523
853 RESPONSE TO ALKALOID 11 137 4.836e-05 0.0002638
854 POSITIVE REGULATION OF RESPONSE TO WOUNDING 12 162 4.896e-05 0.0002668
855 TOLERANCE INDUCTION 4 12 5.019e-05 0.0002719
856 CARTILAGE MORPHOGENESIS 4 12 5.019e-05 0.0002719
857 REGULATION OF VITAMIN METABOLIC PROCESS 4 12 5.019e-05 0.0002719
858 REGULATION OF T CELL TOLERANCE INDUCTION 4 12 5.019e-05 0.0002719
859 REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 4 12 5.019e-05 0.0002719
860 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 7 53 5.106e-05 0.0002756
861 MAMMARY GLAND EPITHELIUM DEVELOPMENT 7 53 5.106e-05 0.0002756
862 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 7 53 5.106e-05 0.0002756
863 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 14 216 5.152e-05 0.0002778
864 RESPONSE TO INCREASED OXYGEN LEVELS 5 23 5.324e-05 0.0002854
865 LEUKOCYTE APOPTOTIC PROCESS 5 23 5.324e-05 0.0002854
866 RESPONSE TO HYPEROXIA 5 23 5.324e-05 0.0002854
867 INNERVATION 5 23 5.324e-05 0.0002854
868 NEUROTROPHIN SIGNALING PATHWAY 5 23 5.324e-05 0.0002854
869 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 6 37 5.429e-05 0.0002904
870 POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 6 37 5.429e-05 0.0002904
871 PROTEIN DEPHOSPHORYLATION 13 190 5.468e-05 0.0002921
872 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 7 54 5.774e-05 0.0003074
873 ALPHA BETA T CELL ACTIVATION 7 54 5.774e-05 0.0003074
874 RESPONSE TO NUTRIENT 13 191 5.772e-05 0.0003074
875 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 10 116 5.828e-05 0.0003099
876 POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 8 73 5.883e-05 0.0003121
877 ACUTE INFLAMMATORY RESPONSE 8 73 5.883e-05 0.0003121
878 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 12 166 6.207e-05 0.0003289
879 REGULATION OF RECEPTOR ACTIVITY 10 117 6.27e-05 0.0003319
880 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 11 141 6.292e-05 0.0003327
881 B CELL PROLIFERATION 6 38 6.348e-05 0.0003341
882 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 6 38 6.348e-05 0.0003341
883 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 6 38 6.348e-05 0.0003341
884 POSITIVE REGULATION OF ORGAN GROWTH 6 38 6.348e-05 0.0003341
885 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 8 74 6.492e-05 0.0003409
886 CELL CELL JUNCTION ASSEMBLY 8 74 6.492e-05 0.0003409
887 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 7 55 6.513e-05 0.0003416
888 CANONICAL WNT SIGNALING PATHWAY 9 95 6.536e-05 0.0003425
889 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 24 6.624e-05 0.0003459
890 RESPONSE TO STEROL 5 24 6.624e-05 0.0003459
891 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 5 24 6.624e-05 0.0003459
892 FC EPSILON RECEPTOR SIGNALING PATHWAY 11 142 6.709e-05 0.00035
893 ANTERIOR POSTERIOR PATTERN SPECIFICATION 13 194 6.771e-05 0.0003528
894 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 16 280 6.97e-05 0.0003627
895 ARTERY DEVELOPMENT 8 75 7.152e-05 0.0003689
896 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 8 75 7.152e-05 0.0003689
897 EYELID DEVELOPMENT IN CAMERA TYPE EYE 4 13 7.145e-05 0.0003689
898 REGULATION OF REGULATORY T CELL DIFFERENTIATION 4 13 7.145e-05 0.0003689
899 CELLULAR GLUCOSE HOMEOSTASIS 8 75 7.152e-05 0.0003689
900 REGULATION OF LEUKOCYTE CHEMOTAXIS 9 96 7.097e-05 0.0003689
901 NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS 4 13 7.145e-05 0.0003689
902 NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 4 13 7.145e-05 0.0003689
903 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 56 7.326e-05 0.0003775
904 POSITIVE REGULATION OF CELL KILLING 6 39 7.386e-05 0.0003802
905 NEGATIVE REGULATION OF DEFENSE RESPONSE 11 144 7.617e-05 0.0003912
906 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 11 144 7.617e-05 0.0003912
907 GLIAL CELL DEVELOPMENT 8 76 7.866e-05 0.0004035
908 RESPONSE TO IONIZING RADIATION 11 145 8.108e-05 0.0004155
909 MEMBRANE ASSEMBLY 5 25 8.156e-05 0.0004166
910 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 5 25 8.156e-05 0.0004166
911 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 25 8.156e-05 0.0004166
912 HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 9 98 8.34e-05 0.000425
913 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 10 121 8.334e-05 0.000425
914 MAMMARY GLAND MORPHOGENESIS 6 40 8.556e-05 0.0004351
915 DEVELOPMENTAL PIGMENTATION 6 40 8.556e-05 0.0004351
916 REGULATION OF BMP SIGNALING PATHWAY 8 77 8.639e-05 0.0004384
917 DEVELOPMENTAL CELL GROWTH 8 77 8.639e-05 0.0004384
918 MYELOID LEUKOCYTE MIGRATION 9 99 9.027e-05 0.0004566
919 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 9 99 9.027e-05 0.0004566
920 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 9 99 9.027e-05 0.0004566
921 LYMPHOCYTE MEDIATED IMMUNITY 11 147 9.173e-05 0.0004634
922 NEGATIVE REGULATION OF WOUND HEALING 7 58 9.203e-05 0.000464
923 REGULATION OF INTERLEUKIN 1 PRODUCTION 7 58 9.203e-05 0.000464
924 STRESS FIBER ASSEMBLY 4 14 9.857e-05 0.0004895
925 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 4 14 9.857e-05 0.0004895
926 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 4 14 9.857e-05 0.0004895
927 REGULATION OF PODOSOME ASSEMBLY 4 14 9.857e-05 0.0004895
928 CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY 4 14 9.857e-05 0.0004895
929 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 4 14 9.857e-05 0.0004895
930 REGULATION OF GLOMERULUS DEVELOPMENT 4 14 9.857e-05 0.0004895
931 RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE 4 14 9.857e-05 0.0004895
932 RESPONSE TO TEMPERATURE STIMULUS 11 148 9.749e-05 0.0004895
933 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 4 14 9.857e-05 0.0004895
934 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 4 14 9.857e-05 0.0004895
935 LIMBIC SYSTEM DEVELOPMENT 9 100 9.761e-05 0.0004895
936 BEHAVIOR 23 516 9.755e-05 0.0004895
937 BONE MATURATION 4 14 9.857e-05 0.0004895
938 DEVELOPMENTAL PROGRAMMED CELL DEATH 5 26 9.946e-05 0.0004918
939 REPLACEMENT OSSIFICATION 5 26 9.946e-05 0.0004918
940 CELLULAR RESPONSE TO INTERLEUKIN 4 5 26 9.946e-05 0.0004918
941 ENDOCHONDRAL OSSIFICATION 5 26 9.946e-05 0.0004918
942 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 10 124 0.0001024 0.0005056
943 VASCULOGENESIS 7 59 0.0001028 0.0005072
944 SINGLE ORGANISM BEHAVIOR 19 384 0.0001038 0.0005115
945 REGULATION OF EXTENT OF CELL GROWTH 9 101 0.0001054 0.0005192
946 DENDRITE MORPHOGENESIS 6 42 0.0001134 0.000557
947 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 6 42 0.0001134 0.000557
948 RESPONSE TO TUMOR NECROSIS FACTOR 14 233 0.000116 0.0005692
949 NEGATIVE REGULATION OF MULTI ORGANISM PROCESS 11 151 0.0001167 0.000572
950 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 27 0.0001202 0.0005882
951 AXIS ELONGATION 5 27 0.0001202 0.0005882
952 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 7 61 0.0001274 0.0006206
953 OVARIAN FOLLICLE DEVELOPMENT 7 61 0.0001274 0.0006206
954 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 7 61 0.0001274 0.0006206
955 REGULATION OF INTERLEUKIN 8 PRODUCTION 7 61 0.0001274 0.0006206
956 NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 6 43 0.0001297 0.0006313
957 ENDOCARDIAL CUSHION FORMATION 4 15 0.0001325 0.000642
958 RESPIRATORY BURST 4 15 0.0001325 0.000642
959 MUSCLE CELL FATE COMMITMENT 4 15 0.0001325 0.000642
960 POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 4 15 0.0001325 0.000642
961 REGULATION OF TRANSMEMBRANE TRANSPORT 20 426 0.0001394 0.0006751
962 FOREBRAIN CELL MIGRATION 7 62 0.0001413 0.0006829
963 CARDIAC VENTRICLE MORPHOGENESIS 7 62 0.0001413 0.0006829
964 POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 5 28 0.0001442 0.0006929
965 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 5 28 0.0001442 0.0006929
966 REGULATION OF NEUROBLAST PROLIFERATION 5 28 0.0001442 0.0006929
967 REGULATION OF SPROUTING ANGIOGENESIS 5 28 0.0001442 0.0006929
968 RESPONSE TO GONADOTROPIN 5 28 0.0001442 0.0006929
969 SENSORY PERCEPTION OF MECHANICAL STIMULUS 11 155 0.0001471 0.0007065
970 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 9 106 0.000153 0.0007338
971 NEUROEPITHELIAL CELL DIFFERENTIATION 7 63 0.0001565 0.00075
972 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 84 0.0001601 0.0007662
973 RESPONSE TO TOXIC SUBSTANCE 14 241 0.0001652 0.00079
974 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 6 45 0.000168 0.0008026
975 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 5 29 0.0001716 0.0008163
976 STEM CELL DIVISION 5 29 0.0001716 0.0008163
977 REGULATION OF HEART MORPHOGENESIS 5 29 0.0001716 0.0008163
978 POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION 5 29 0.0001716 0.0008163
979 NEGATIVE REGULATION OF TRANSPORTER ACTIVITY 7 64 0.000173 0.0008221
980 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 8 85 0.0001739 0.0008222
981 TOLL LIKE RECEPTOR SIGNALING PATHWAY 8 85 0.0001739 0.0008222
982 NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION 4 16 0.0001741 0.0008222
983 EPHRIN RECEPTOR SIGNALING PATHWAY 8 85 0.0001739 0.0008222
984 REGULATION OF INTERLEUKIN 6 BIOSYNTHETIC PROCESS 4 16 0.0001741 0.0008222
985 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 4 16 0.0001741 0.0008222
986 MUCOPOLYSACCHARIDE METABOLIC PROCESS 9 108 0.0001764 0.0008326
987 REGULATION OF JNK CASCADE 11 159 0.0001841 0.000868
988 NEGATIVE REGULATION OF DNA BINDING 6 46 0.0001902 0.0008959
989 HUMORAL IMMUNE RESPONSE 12 187 0.0001924 0.0009052
990 REGULATION OF PROTEIN TARGETING 16 307 0.0002018 0.0009486
991 LEUKOCYTE DEGRANULATION 5 30 0.0002028 0.0009493
992 POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 5 30 0.0002028 0.0009493
993 MEMBRANE BIOGENESIS 5 30 0.0002028 0.0009493
994 RESPONSE TO GROWTH HORMONE 5 30 0.0002028 0.0009493
995 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 0.0002045 0.0009497
996 NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT 8 87 0.0002045 0.0009497
997 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 0.0002045 0.0009497
998 VIRAL ENTRY INTO HOST CELL 8 87 0.0002045 0.0009497
999 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 0.0002045 0.0009497
1000 MOVEMENT IN HOST ENVIRONMENT 8 87 0.0002045 0.0009497
1001 ENTRY INTO HOST 8 87 0.0002045 0.0009497
1002 ENTRY INTO HOST CELL 8 87 0.0002045 0.0009497
1003 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 7 66 0.0002101 0.0009738
1004 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 7 66 0.0002101 0.0009738
1005 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 11 162 0.0002168 0.001004
1006 MYELOID CELL HOMEOSTASIS 8 88 0.0002214 0.001024
1007 REGULATION OF DEFENSE RESPONSE TO VIRUS 12 190 0.000223 0.001028
1008 BRANCH ELONGATION OF AN EPITHELIUM 4 17 0.0002243 0.001028
1009 ANATOMICAL STRUCTURE ARRANGEMENT 4 17 0.0002243 0.001028
1010 NEGATIVE REGULATION OF ANOIKIS 4 17 0.0002243 0.001028
1011 POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 4 17 0.0002243 0.001028
1012 MATURE B CELL DIFFERENTIATION 4 17 0.0002243 0.001028
1013 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 4 17 0.0002243 0.001028
1014 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 17 0.0002243 0.001028
1015 NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 4 17 0.0002243 0.001028
1016 CELL CYCLE PROCESS 37 1081 0.0002284 0.001046
1017 POSITIVE REGULATION OF NEURON DEATH 7 67 0.000231 0.001056
1018 REGULATION OF NOTCH SIGNALING PATHWAY 7 67 0.000231 0.001056
1019 EAR MORPHOGENESIS 9 112 0.0002324 0.001061
1020 DIVALENT INORGANIC CATION HOMEOSTASIS 17 343 0.0002333 0.001064
1021 ORGANOPHOSPHATE METABOLIC PROCESS 32 885 0.0002362 0.001076
1022 RESPONSE TO INTERLEUKIN 4 5 31 0.0002382 0.001079
1023 HYALURONAN METABOLIC PROCESS 5 31 0.0002382 0.001079
1024 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 13 220 0.0002378 0.001079
1025 MACROPHAGE ACTIVATION 5 31 0.0002382 0.001079
1026 REGULATION OF PLATELET ACTIVATION 5 31 0.0002382 0.001079
1027 REGULATION OF SYNAPTIC VESICLE TRANSPORT 5 31 0.0002382 0.001079
1028 SEGMENTATION 8 89 0.0002394 0.001084
1029 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 6 48 0.0002416 0.001087
1030 NEGATIVE REGULATION OF COAGULATION 6 48 0.0002416 0.001087
1031 REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 6 48 0.0002416 0.001087
1032 IMMUNOGLOBULIN PRODUCTION 6 48 0.0002416 0.001087
1033 DIGESTIVE TRACT MORPHOGENESIS 6 48 0.0002416 0.001087
1034 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 6 48 0.0002416 0.001087
1035 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 7 68 0.0002535 0.001138
1036 REGULATION OF PHAGOCYTOSIS 7 68 0.0002535 0.001138
1037 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 8 90 0.0002586 0.00116
1038 CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 14 252 0.0002617 0.001173
1039 NOTCH SIGNALING PATHWAY 9 114 0.0002655 0.001188
1040 REGULATION OF EMBRYONIC DEVELOPMENT 9 114 0.0002655 0.001188
1041 MULTI ORGANISM REPRODUCTIVE PROCESS 32 891 0.0002661 0.001189
1042 AMINOGLYCAN METABOLIC PROCESS 11 166 0.0002679 0.001196
1043 REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 6 49 0.0002711 0.001208
1044 CARDIAC CELL DEVELOPMENT 6 49 0.0002711 0.001208
1045 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 18 381 0.0002764 0.001231
1046 MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 5 32 0.000278 0.001232
1047 REGULATION OF ORGAN FORMATION 5 32 0.000278 0.001232
1048 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 5 32 0.000278 0.001232
1049 METANEPHRIC NEPHRON DEVELOPMENT 5 32 0.000278 0.001232
1050 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 5 32 0.000278 0.001232
1051 REGULATION OF TOLERANCE INDUCTION 4 18 0.0002842 0.001256
1052 ATRIAL SEPTUM DEVELOPMENT 4 18 0.0002842 0.001256
1053 PHARYNGEAL SYSTEM DEVELOPMENT 4 18 0.0002842 0.001256
1054 PROTEIN LOCALIZATION TO ORGANELLE 23 556 0.0002881 0.001272
1055 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 11 168 0.000297 0.00131
1056 PROTEIN SECRETION 9 116 0.0003023 0.001332
1057 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 6 50 0.0003034 0.001333
1058 RECEPTOR INTERNALIZATION 6 50 0.0003034 0.001333
1059 RESPONSE TO PROGESTERONE 6 50 0.0003034 0.001333
1060 WNT SIGNALING PATHWAY 17 351 0.000305 0.001339
1061 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 12 197 0.0003109 0.001363
1062 APPENDAGE DEVELOPMENT 11 169 0.0003126 0.001368
1063 LIMB DEVELOPMENT 11 169 0.0003126 0.001368
1064 REGULATION OF MYELINATION 5 33 0.0003228 0.001412
1065 CELLULAR RESPONSE TO OXYGEN LEVELS 10 143 0.0003292 0.001438
1066 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 51 0.0003385 0.001476
1067 NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 6 51 0.0003385 0.001476
1068 TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 9 118 0.0003434 0.001496
1069 MACROPHAGE DIFFERENTIATION 4 19 0.0003548 0.001541
1070 MUSCLE CELL CELLULAR HOMEOSTASIS 4 19 0.0003548 0.001541
1071 ASTROCYTE DEVELOPMENT 4 19 0.0003548 0.001541
1072 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 10 145 0.0003678 0.001597
1073 POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY 5 34 0.0003727 0.001615
1074 PROTEIN KINASE B SIGNALING 5 34 0.0003727 0.001615
1075 FC GAMMA RECEPTOR SIGNALING PATHWAY 8 95 0.0003745 0.001621
1076 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 6 52 0.0003768 0.001628
1077 NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 6 52 0.0003768 0.001628
1078 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 9 120 0.0003889 0.001677
1079 CELLULAR RESPONSE TO INSULIN STIMULUS 10 146 0.0003885 0.001677
1080 CELLULAR RESPONSE TO ABIOTIC STIMULUS 14 263 0.0004033 0.001737
1081 PLASMA MEMBRANE ORGANIZATION 12 203 0.0004081 0.001757
1082 REGULATION OF BLOOD CIRCULATION 15 295 0.0004111 0.001768
1083 REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY 6 53 0.0004184 0.001798
1084 BONE REMODELING 5 35 0.0004284 0.001837
1085 NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION 5 35 0.0004284 0.001837
1086 EMBRYONIC HEMOPOIESIS 4 20 0.0004371 0.001864
1087 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 4 20 0.0004371 0.001864
1088 RESPONSE TO LIPOPROTEIN PARTICLE 4 20 0.0004371 0.001864
1089 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN 4 20 0.0004371 0.001864
1090 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 4 20 0.0004371 0.001864
1091 MYELOID DENDRITIC CELL DIFFERENTIATION 4 20 0.0004371 0.001864
1092 POSITIVE REGULATION OF CALCIUM ION IMPORT 6 54 0.0004635 0.001975
1093 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 7 75 0.0004648 0.001977
1094 POSITIVE REGULATION OF AUTOPHAGY 7 75 0.0004648 0.001977
1095 ION HOMEOSTASIS 23 576 0.0004721 0.002006
1096 DEFENSE RESPONSE TO BACTERIUM 13 237 0.0004858 0.002062
1097 T CELL PROLIFERATION 5 36 0.00049 0.002073
1098 POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 5 36 0.00049 0.002073
1099 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 5 36 0.00049 0.002073
1100 T CELL SELECTION 5 36 0.00049 0.002073
1101 PROTEIN LOCALIZATION TO CELL PERIPHERY 10 151 0.0005072 0.002143
1102 CHONDROCYTE DEVELOPMENT 4 21 0.0005321 0.002235
1103 MAST CELL ACTIVATION 4 21 0.0005321 0.002235
1104 CELL AGGREGATION 4 21 0.0005321 0.002235
1105 POSITIVE T CELL SELECTION 4 21 0.0005321 0.002235
1106 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 8 100 0.0005295 0.002235
1107 FIBRINOLYSIS 4 21 0.0005321 0.002235
1108 CARTILAGE CONDENSATION 4 21 0.0005321 0.002235
1109 POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 5 37 0.0005581 0.002337
1110 MYOBLAST DIFFERENTIATION 5 37 0.0005581 0.002337
1111 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 5 37 0.0005581 0.002337
1112 MULTICELLULAR ORGANISMAL HOMEOSTASIS 14 272 0.0005635 0.002358
1113 CAMERA TYPE EYE MORPHOGENESIS 8 101 0.000566 0.002366
1114 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 7 78 0.0005903 0.002465
1115 RENAL SYSTEM PROCESS 8 102 0.0006045 0.002522
1116 REGULATION OF PHOSPHATASE ACTIVITY 9 128 0.0006234 0.002597
1117 NEGATIVE REGULATION OF HEMOPOIESIS 9 128 0.0006234 0.002597
1118 REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 38 0.000633 0.002635
1119 BONE CELL DEVELOPMENT 4 22 0.000641 0.002651
1120 REGULATION OF B CELL DIFFERENTIATION 4 22 0.000641 0.002651
1121 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 4 22 0.000641 0.002651
1122 REGULATION OF INTERLEUKIN 17 PRODUCTION 4 22 0.000641 0.002651
1123 PROTEIN LOCALIZATION TO CELL SURFACE 4 22 0.000641 0.002651
1124 SOMATIC STEM CELL DIVISION 4 22 0.000641 0.002651
1125 REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 4 22 0.000641 0.002651
1126 NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 10 156 0.0006544 0.002704
1127 TYROSINE PHOSPHORYLATION OF STAT PROTEIN 3 10 0.0006789 0.002803
1128 CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 6 58 0.0006828 0.002814
1129 POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 6 58 0.0006828 0.002814
1130 CELLULAR RESPONSE TO MECHANICAL STIMULUS 7 80 0.0006878 0.002832
1131 REGULATION OF EXOCYTOSIS 11 186 0.0007016 0.002886
1132 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 5 39 0.0007152 0.002927
1133 RESPONSE TO RADIATION 18 413 0.0007152 0.002927
1134 CELL CYCLE 41 1316 0.0007153 0.002927
1135 COCHLEA DEVELOPMENT 5 39 0.0007152 0.002927
1136 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 5 39 0.0007152 0.002927
1137 EMBRYO IMPLANTATION 5 39 0.0007152 0.002927
1138 REGULATION OF DEPHOSPHORYLATION 10 158 0.0007224 0.002954
1139 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 7 81 0.0007412 0.003025
1140 REGULATION OF JUN KINASE ACTIVITY 7 81 0.0007412 0.003025
1141 POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 4 23 0.0007647 0.003102
1142 CRANIAL NERVE MORPHOGENESIS 4 23 0.0007647 0.003102
1143 POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 4 23 0.0007647 0.003102
1144 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 23 0.0007647 0.003102
1145 EPIBOLY 4 23 0.0007647 0.003102
1146 POSITIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS 4 23 0.0007647 0.003102
1147 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 4 23 0.0007647 0.003102
1148 REGULATION OF AUTOPHAGY 13 249 0.0007706 0.003124
1149 CARDIAC VENTRICLE DEVELOPMENT 8 106 0.0007801 0.003159
1150 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 7 82 0.0007977 0.003228
1151 APICAL JUNCTION ASSEMBLY 5 40 0.0008052 0.003238
1152 FORELIMB MORPHOGENESIS 5 40 0.0008052 0.003238
1153 REGULATION OF ACTIVATED T CELL PROLIFERATION 5 40 0.0008052 0.003238
1154 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 5 40 0.0008052 0.003238
1155 HINDBRAIN MORPHOGENESIS 5 40 0.0008052 0.003238
1156 MUSCLE SYSTEM PROCESS 14 282 0.0008019 0.003238
1157 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 5 40 0.0008052 0.003238
1158 REGULATION OF MONOOXYGENASE ACTIVITY 6 60 0.0008189 0.003288
1159 OLIGODENDROCYTE DIFFERENTIATION 6 60 0.0008189 0.003288
1160 COGNITION 13 251 0.0008296 0.003328
1161 REGULATION OF DNA REPLICATION 10 161 0.0008352 0.003347
1162 CELLULAR LIPID METABOLIC PROCESS 31 913 0.0008431 0.003376
1163 PROTEOGLYCAN METABOLIC PROCESS 7 83 0.0008577 0.003431
1164 REGULATION OF HEART CONTRACTION 12 221 0.0008662 0.003461
1165 INTERACTION WITH HOST 9 134 0.0008665 0.003461
1166 NEGATIVE REGULATION OF PROTEIN SECRETION 8 108 0.0008821 0.00352
1167 ANATOMICAL STRUCTURE HOMEOSTASIS 14 285 0.0008883 0.003542
1168 MEMBRANE DEPOLARIZATION 6 61 0.0008944 0.00356
1169 NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 6 61 0.0008944 0.00356
1170 REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 5 41 0.0009033 0.003563
1171 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 4 24 0.0009044 0.003563
1172 REGULATION OF MYELOID CELL APOPTOTIC PROCESS 4 24 0.0009044 0.003563
1173 POSITIVE REGULATION OF INTERLEUKIN 1 SECRETION 4 24 0.0009044 0.003563
1174 AORTA DEVELOPMENT 5 41 0.0009033 0.003563
1175 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 24 0.0009044 0.003563
1176 POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 4 24 0.0009044 0.003563
1177 REGULATION OF ODONTOGENESIS 4 24 0.0009044 0.003563
1178 IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE 4 24 0.0009044 0.003563
1179 REGULATION OF ISOTYPE SWITCHING 4 24 0.0009044 0.003563
1180 REGULATION OF ANOIKIS 4 24 0.0009044 0.003563
1181 CELLULAR RESPONSE TO ESTROGEN STIMULUS 5 41 0.0009033 0.003563
1182 BONE TRABECULA MORPHOGENESIS 3 11 0.0009207 0.003594
1183 NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 3 11 0.0009207 0.003594
1184 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 9 135 0.0009136 0.003594
1185 CARDIAC CELL FATE COMMITMENT 3 11 0.0009207 0.003594
1186 POSITIVE REGULATION OF HAIR CYCLE 3 11 0.0009207 0.003594
1187 REGULATION OF CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE 3 11 0.0009207 0.003594
1188 NEGATIVE REGULATION OF CELLULAR SENESCENCE 3 11 0.0009207 0.003594
1189 EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 3 11 0.0009207 0.003594
1190 NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 3 11 0.0009207 0.003594
1191 REGULATION OF NECROPTOTIC PROCESS 3 11 0.0009207 0.003594
1192 POSITIVE REGULATION OF MYELINATION 3 11 0.0009207 0.003594
1193 RESPONSE TO ETHANOL 9 136 0.0009628 0.003755
1194 EMBRYONIC HEART TUBE MORPHOGENESIS 6 62 0.0009751 0.0038
1195 REGULATION OF NIK NF KAPPAB SIGNALING 5 42 0.00101 0.003933
1196 NEGATIVE REGULATION OF DNA METABOLIC PROCESS 8 111 0.001055 0.004101
1197 REGULATION OF TYPE I INTERFERON PRODUCTION 8 111 0.001055 0.004101
1198 POSITIVE REGULATION OF COAGULATION 4 25 0.001061 0.004108
1199 PIGMENTATION 7 86 0.001059 0.004108
1200 EPITHELIAL CELL APOPTOTIC PROCESS 4 25 0.001061 0.004108
1201 HISTONE PHOSPHORYLATION 4 25 0.001061 0.004108
1202 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 4 25 0.001061 0.004108
1203 REGULATION OF PROTEIN CATABOLIC PROCESS 17 393 0.001082 0.004186
1204 CRANIAL NERVE DEVELOPMENT 5 43 0.001126 0.004344
1205 MORPHOGENESIS OF AN EPITHELIAL SHEET 5 43 0.001126 0.004344
1206 ACUTE PHASE RESPONSE 5 43 0.001126 0.004344
1207 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 7 87 0.001134 0.004371
1208 POSITIVE REGULATION OF CATABOLIC PROCESS 17 395 0.001143 0.004404
1209 REGULATION OF PROTEIN ACETYLATION 6 64 0.001153 0.004438
1210 REGULATION OF TRANSPORTER ACTIVITY 11 198 0.00117 0.004499
1211 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 8 113 0.001184 0.004547
1212 PROTEIN HETEROOLIGOMERIZATION 8 113 0.001184 0.004547
1213 REGULATION OF TIMING OF CELL DIFFERENTIATION 3 12 0.001211 0.004603
1214 POSITIVE REGULATION OF THYMOCYTE AGGREGATION 3 12 0.001211 0.004603
1215 HEMATOPOIETIC STEM CELL DIFFERENTIATION 3 12 0.001211 0.004603
1216 REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 3 12 0.001211 0.004603
1217 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 3 12 0.001211 0.004603
1218 MAINTENANCE OF CELL POLARITY 3 12 0.001211 0.004603
1219 REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS 3 12 0.001211 0.004603
1220 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 3 12 0.001211 0.004603
1221 REGULATION OF DEVELOPMENT HETEROCHRONIC 3 12 0.001211 0.004603
1222 POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS 3 12 0.001211 0.004603
1223 CELL ADHESION MEDIATED BY INTEGRIN 3 12 0.001211 0.004603
1224 RENAL ABSORPTION 3 12 0.001211 0.004603
1225 REGULATION OF CELLULAR SENESCENCE 4 26 0.001236 0.004668
1226 HEART TRABECULA MORPHOGENESIS 4 26 0.001236 0.004668
1227 REGULATION OF T CELL DIFFERENTIATION IN THYMUS 4 26 0.001236 0.004668
1228 REGULATION OF THYMOCYTE AGGREGATION 4 26 0.001236 0.004668
1229 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 4 26 0.001236 0.004668
1230 MESODERMAL CELL DIFFERENTIATION 4 26 0.001236 0.004668
1231 INACTIVATION OF MAPK ACTIVITY 4 26 0.001236 0.004668
1232 MYELOID DENDRITIC CELL ACTIVATION 4 26 0.001236 0.004668
1233 POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION 6 65 0.001251 0.004717
1234 NEGATIVE REGULATION OF AXONOGENESIS 6 65 0.001251 0.004717
1235 NEGATIVE REGULATION OF CELL GROWTH 10 170 0.001264 0.004761
1236 TISSUE HOMEOSTASIS 10 171 0.001321 0.004972
1237 REGULATION OF CARDIAC MUSCLE CONTRACTION 6 66 0.001355 0.005093
1238 LENS DEVELOPMENT IN CAMERA TYPE EYE 6 66 0.001355 0.005093
1239 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 9 143 0.001371 0.005147
1240 ENDOTHELIAL CELL DEVELOPMENT 5 45 0.001387 0.005174
1241 POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 5 45 0.001387 0.005174
1242 THYMOCYTE AGGREGATION 5 45 0.001387 0.005174
1243 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 5 45 0.001387 0.005174
1244 SUBSTANTIA NIGRA DEVELOPMENT 5 45 0.001387 0.005174
1245 MIDBRAIN DEVELOPMENT 7 90 0.001383 0.005174
1246 T CELL DIFFERENTIATION IN THYMUS 5 45 0.001387 0.005174
1247 REGULATION OF GLIOGENESIS 7 90 0.001383 0.005174
1248 SKELETAL MUSCLE TISSUE REGENERATION 4 27 0.00143 0.005289
1249 REGULATION OF ACTIN NUCLEATION 4 27 0.00143 0.005289
1250 SARCOMERE ORGANIZATION 4 27 0.00143 0.005289
1251 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 4 27 0.00143 0.005289
1252 POSITIVE REGULATION OF FILOPODIUM ASSEMBLY 4 27 0.00143 0.005289
1253 POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 4 27 0.00143 0.005289
1254 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 11 203 0.001429 0.005289
1255 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 4 27 0.00143 0.005289
1256 SUBSTRATE DEPENDENT CELL MIGRATION 4 27 0.00143 0.005289
1257 HETEROTYPIC CELL CELL ADHESION 4 27 0.00143 0.005289
1258 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 4 27 0.00143 0.005289
1259 CELLULAR RESPONSE TO DRUG 6 67 0.001466 0.005417
1260 ENSHEATHMENT OF NEURONS 7 91 0.001475 0.005443
1261 AXON ENSHEATHMENT 7 91 0.001475 0.005443
1262 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 8 117 0.001482 0.005458
1263 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 8 117 0.001482 0.005458
1264 MODULATION OF SYNAPTIC TRANSMISSION 14 301 0.001493 0.005494
1265 CELLULAR COMPONENT DISASSEMBLY 20 515 0.001518 0.005585
1266 POSITIVE REGULATION OF ION TRANSPORT 12 236 0.001521 0.005589
1267 CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS 3 13 0.001553 0.005627
1268 REGULATION OF HEPATOCYTE PROLIFERATION 3 13 0.001553 0.005627
1269 NEURONAL STEM CELL DIVISION 3 13 0.001553 0.005627
1270 POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS 3 13 0.001553 0.005627
1271 REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 3 13 0.001553 0.005627
1272 POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 3 13 0.001553 0.005627
1273 HEPATOCYTE APOPTOTIC PROCESS 3 13 0.001553 0.005627
1274 CARDIOBLAST DIFFERENTIATION 3 13 0.001553 0.005627
1275 REGULATION OF HISTONE PHOSPHORYLATION 3 13 0.001553 0.005627
1276 INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 3 13 0.001553 0.005627
1277 RESPONSE TO PARATHYROID HORMONE 3 13 0.001553 0.005627
1278 NEUROBLAST DIVISION 3 13 0.001553 0.005627
1279 MESENCHYMAL CELL PROLIFERATION 3 13 0.001553 0.005627
1280 MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE 3 13 0.001553 0.005627
1281 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 3 13 0.001553 0.005627
1282 VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT 3 13 0.001553 0.005627
1283 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 3 13 0.001553 0.005627
1284 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 3 13 0.001553 0.005627
1285 INNER EAR MORPHOGENESIS 7 92 0.001572 0.005692
1286 REGULATION OF RESPONSE TO BIOTIC STIMULUS 12 237 0.001576 0.005702
1287 ORGAN GROWTH 6 68 0.001583 0.005723
1288 REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 4 28 0.001644 0.005917
1289 NECROTIC CELL DEATH 4 28 0.001644 0.005917
1290 REGULATION OF FIBROBLAST MIGRATION 4 28 0.001644 0.005917
1291 NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 4 28 0.001644 0.005917
1292 T CELL MEDIATED IMMUNITY 4 28 0.001644 0.005917
1293 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 0.001644 0.005917
1294 POSITIVE REGULATION OF BLOOD CIRCULATION 7 93 0.001673 0.006017
1295 NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 5 47 0.001689 0.006052
1296 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 5 47 0.001689 0.006052
1297 RESPONSE TO ANTIBIOTIC 5 47 0.001689 0.006052
1298 NEURON DEATH 5 47 0.001689 0.006052
1299 POSITIVE REGULATION OF GLIOGENESIS 5 47 0.001689 0.006052
1300 RESPONSE TO ACTIVITY 6 69 0.001707 0.006111
1301 RESPONSE TO TRANSITION METAL NANOPARTICLE 9 148 0.001739 0.006216
1302 REGULATION OF ORGANELLE ASSEMBLY 9 148 0.001739 0.006216
1303 REGULATION OF DENDRITE DEVELOPMENT 8 120 0.001741 0.006217
1304 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 11 209 0.001801 0.006426
1305 NEURAL TUBE DEVELOPMENT 9 149 0.001822 0.006495
1306 MUSCLE ORGAN MORPHOGENESIS 6 70 0.001839 0.006546
1307 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 6 70 0.001839 0.006546
1308 REGULATION OF MYOBLAST DIFFERENTIATION 5 48 0.001858 0.006599
1309 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 5 48 0.001858 0.006599
1310 POSITIVE REGULATION OF WOUND HEALING 5 48 0.001858 0.006599
1311 PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 4 29 0.00188 0.006652
1312 POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING 4 29 0.00188 0.006652
1313 PIGMENT CELL DIFFERENTIATION 4 29 0.00188 0.006652
1314 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 4 29 0.00188 0.006652
1315 POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY 4 29 0.00188 0.006652
1316 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 3 14 0.001949 0.006835
1317 PROTEIN HETEROTRIMERIZATION 3 14 0.001949 0.006835
1318 ATRIAL SEPTUM MORPHOGENESIS 3 14 0.001949 0.006835
1319 T CELL MIGRATION 3 14 0.001949 0.006835
1320 METANEPHRIC MESENCHYME DEVELOPMENT 3 14 0.001949 0.006835
1321 REGULATION OF MONOCYTE DIFFERENTIATION 3 14 0.001949 0.006835
1322 HEART TRABECULA FORMATION 3 14 0.001949 0.006835
1323 POSITIVE REGULATION OF B CELL DIFFERENTIATION 3 14 0.001949 0.006835
1324 ANGIOGENESIS INVOLVED IN WOUND HEALING 3 14 0.001949 0.006835
1325 REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 3 14 0.001949 0.006835
1326 RESPONSE TO LAMINAR FLUID SHEAR STRESS 3 14 0.001949 0.006835
1327 ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN 3 14 0.001949 0.006835
1328 SKIN EPIDERMIS DEVELOPMENT 6 71 0.001978 0.006925
1329 CELL FATE SPECIFICATION 6 71 0.001978 0.006925
1330 PROTEIN COMPLEX BIOGENESIS 35 1132 0.001997 0.00698
1331 PROTEIN COMPLEX ASSEMBLY 35 1132 0.001997 0.00698
1332 CELLULAR RESPONSE TO CALCIUM ION 5 49 0.002038 0.007109
1333 REGULATION OF STEROID BIOSYNTHETIC PROCESS 5 49 0.002038 0.007109
1334 CARDIAC SEPTUM MORPHOGENESIS 5 49 0.002038 0.007109
1335 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 9 152 0.002088 0.007278
1336 ANTIGEN PROCESSING AND PRESENTATION 11 213 0.00209 0.007279
1337 ESTABLISHMENT OF ENDOTHELIAL BARRIER 4 30 0.002138 0.007429
1338 CELLULAR RESPONSE TO ESTRADIOL STIMULUS 4 30 0.002138 0.007429
1339 OSTEOCLAST DIFFERENTIATION 4 30 0.002138 0.007429
1340 POSITIVE REGULATION OF CELL CYCLE PROCESS 12 247 0.002224 0.007724
1341 REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 50 0.002231 0.007729
1342 CELLULAR RESPONSE TO CAMP 5 50 0.002231 0.007729
1343 RHO PROTEIN SIGNAL TRANSDUCTION 5 50 0.002231 0.007729
1344 EMBRYONIC HEART TUBE DEVELOPMENT 6 73 0.00228 0.007887
1345 HIPPOCAMPUS DEVELOPMENT 6 73 0.00228 0.007887
1346 CELL DIVISION 18 460 0.00237 0.008192
1347 HYALURONAN CATABOLIC PROCESS 3 15 0.002404 0.008223
1348 REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 3 15 0.002404 0.008223
1349 RESPONSE TO MURAMYL DIPEPTIDE 3 15 0.002404 0.008223
1350 REGULATION OF HAIR FOLLICLE DEVELOPMENT 3 15 0.002404 0.008223
1351 NEGATIVE REGULATION OF HISTONE ACETYLATION 3 15 0.002404 0.008223
1352 MORPHOGENESIS OF AN EPITHELIAL FOLD 3 15 0.002404 0.008223
1353 NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 3 15 0.002404 0.008223
1354 NEGATIVE REGULATION OF B CELL PROLIFERATION 3 15 0.002404 0.008223
1355 REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 3 15 0.002404 0.008223
1356 REGULATION OF CELL PROJECTION ASSEMBLY 9 155 0.002384 0.008223
1357 NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 3 15 0.002404 0.008223
1358 EPITHELIAL CELL FATE COMMITMENT 3 15 0.002404 0.008223
1359 T CELL APOPTOTIC PROCESS 3 15 0.002404 0.008223
1360 CELLULAR RESPONSE TO GONADOTROPIN STIMULUS 3 15 0.002404 0.008223
1361 REGULATION OF INTERLEUKIN 4 PRODUCTION 4 31 0.002419 0.008229
1362 REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 4 31 0.002419 0.008229
1363 CARDIAC ATRIUM DEVELOPMENT 4 31 0.002419 0.008229
1364 REGULATION OF MICROTUBULE POLYMERIZATION 4 31 0.002419 0.008229
1365 REGULATION OF MAST CELL DEGRANULATION 4 31 0.002419 0.008229
1366 NEURON FATE SPECIFICATION 4 31 0.002419 0.008229
1367 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 4 31 0.002419 0.008229
1368 SCHWANN CELL DIFFERENTIATION 4 31 0.002419 0.008229
1369 REGULATION OF NEUROTRANSMITTER SECRETION 5 51 0.002437 0.008276
1370 NEGATIVE REGULATION OF CALCIUM ION TRANSPORT 5 51 0.002437 0.008276
1371 REGULATION OF DENDRITE MORPHOGENESIS 6 74 0.002443 0.008286
1372 REGULATION OF ACUTE INFLAMMATORY RESPONSE 6 74 0.002443 0.008286
1373 GRANULOCYTE MIGRATION 6 75 0.002615 0.008863
1374 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 5 52 0.002656 0.008961
1375 NEGATIVE REGULATION OF T CELL PROLIFERATION 5 52 0.002656 0.008961
1376 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 5 52 0.002656 0.008961
1377 CELLULAR RESPONSE TO IONIZING RADIATION 5 52 0.002656 0.008961
1378 DEPHOSPHORYLATION 13 286 0.002654 0.008961
1379 ACTIVATION OF MAPKK ACTIVITY 5 52 0.002656 0.008961
1380 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 4 32 0.002725 0.009176
1381 POSITIVE REGULATION OF DENDRITE MORPHOGENESIS 4 32 0.002725 0.009176
1382 POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY 4 32 0.002725 0.009176
1383 DEFENSE RESPONSE TO OTHER ORGANISM 19 505 0.002806 0.009442
1384 MODULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST 3 16 0.002918 0.009671
1385 POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION 3 16 0.002918 0.009671
1386 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 3 16 0.002918 0.009671
1387 REGULATION OF MONONUCLEAR CELL MIGRATION 3 16 0.002918 0.009671
1388 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 5 53 0.002889 0.009671
1389 POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY 3 16 0.002918 0.009671
1390 NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 3 16 0.002918 0.009671
1391 REGULATION OF MACROPHAGE CHEMOTAXIS 3 16 0.002918 0.009671
1392 CYTOSOLIC CALCIUM ION TRANSPORT 5 53 0.002889 0.009671
1393 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 5 53 0.002889 0.009671
1394 POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 3 16 0.002918 0.009671
1395 POSITIVE REGULATION OF ACTIN NUCLEATION 3 16 0.002918 0.009671
1396 MEGAKARYOCYTE DEVELOPMENT 3 16 0.002918 0.009671
1397 NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 5 53 0.002889 0.009671
1398 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 3 16 0.002918 0.009671
1399 PARAXIAL MESODERM DEVELOPMENT 3 16 0.002918 0.009671
1400 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN 3 16 0.002918 0.009671
1401 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 3 16 0.002918 0.009671
1402 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 3 16 0.002918 0.009671
1403 ATRIOVENTRICULAR VALVE MORPHOGENESIS 3 16 0.002918 0.009671
1404 MONOCYTE DIFFERENTIATION 3 16 0.002918 0.009671
1405 REGULATION OF SODIUM ION TRANSPORT 6 77 0.002986 0.009876
1406 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 6 77 0.002986 0.009876
1407 DIENCEPHALON DEVELOPMENT 6 77 0.002986 0.009876
1408 LEARNING 8 131 0.003012 0.009953
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 118 1476 7.683e-45 7.137e-42
2 ENZYME BINDING 98 1737 1.811e-24 8.413e-22
3 MACROMOLECULAR COMPLEX BINDING 86 1399 8.779e-24 2.718e-21
4 GROWTH FACTOR ACTIVITY 30 160 9.23e-22 2.144e-19
5 PROTEIN TYROSINE KINASE ACTIVITY 31 176 1.334e-21 2.479e-19
6 KINASE BINDING 52 606 1.58e-20 1.939e-18
7 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 39 328 1.669e-20 1.939e-18
8 CYTOKINE RECEPTOR BINDING 36 271 1.275e-20 1.939e-18
9 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 52 629 8.241e-20 8.507e-18
10 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 37 315 2.553e-19 2.312e-17
11 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 32 226 2.738e-19 2.312e-17
12 KINASE ACTIVITY 59 842 6.567e-19 5.084e-17
13 PROTEIN KINASE ACTIVITY 51 640 9.392e-19 6.711e-17
14 REGULATORY REGION NUCLEIC ACID BINDING 54 818 3.153e-16 2.092e-14
15 PROTEIN COMPLEX BINDING 58 935 3.623e-16 2.244e-14
16 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 59 992 1.303e-15 7.563e-14
17 RIBONUCLEOTIDE BINDING 85 1860 2.018e-15 1.103e-13
18 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 17 70 7.46e-15 3.85e-13
19 SEQUENCE SPECIFIC DNA BINDING 59 1037 9.359e-15 4.576e-13
20 CORE PROMOTER PROXIMAL REGION DNA BINDING 34 371 1.469e-14 6.825e-13
21 CYTOKINE ACTIVITY 26 219 5.074e-14 2.245e-12
22 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 61 1199 4.41e-13 1.803e-11
23 PROTEIN DOMAIN SPECIFIC BINDING 42 624 4.463e-13 1.803e-11
24 GROWTH FACTOR BINDING 19 123 1.206e-12 4.669e-11
25 NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY 13 46 1.366e-12 5.077e-11
26 DOUBLE STRANDED DNA BINDING 46 764 1.64e-12 5.859e-11
27 GROWTH FACTOR RECEPTOR BINDING 19 129 2.897e-12 9.967e-11
28 IDENTICAL PROTEIN BINDING 59 1209 6.349e-12 2.107e-10
29 MOLECULAR FUNCTION REGULATOR 63 1353 8.179e-12 2.62e-10
30 GUANYL NUCLEOTIDE BINDING 31 390 9.493e-12 2.94e-10
31 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 15 81 1.987e-11 5.955e-10
32 GTPASE ACTIVITY 24 246 3.38e-11 9.813e-10
33 CELL ADHESION MOLECULE BINDING 21 186 3.786e-11 1.066e-09
34 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 23 228 4.449e-11 1.216e-09
35 SMAD BINDING 14 72 4.701e-11 1.248e-09
36 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 12 50 8.415e-11 2.171e-09
37 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 26 303 8.945e-11 2.246e-09
38 INTEGRIN BINDING 16 105 9.192e-11 2.247e-09
39 PLATELET DERIVED GROWTH FACTOR BINDING 7 11 2.13e-10 5.073e-09
40 GLYCOSAMINOGLYCAN BINDING 21 205 2.375e-10 5.516e-09
41 GLYCOPROTEIN BINDING 15 101 5.196e-10 1.177e-08
42 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 14 90 1.053e-09 2.329e-08
43 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 11 64 2.254e-08 4.869e-07
44 SIGNAL TRANSDUCER ACTIVITY 65 1731 2.501e-08 5.28e-07
45 TRANSCRIPTION FACTOR BINDING 30 524 4.72e-08 9.745e-07
46 PROTEASE BINDING 13 104 6.26e-08 1.264e-06
47 PROTEIN DIMERIZATION ACTIVITY 48 1149 1.009e-07 1.994e-06
48 CYTOKINE BINDING 12 92 1.254e-07 2.427e-06
49 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 6 15 1.647e-07 3.123e-06
50 SH3 DOMAIN BINDING 13 116 2.307e-07 4.287e-06
51 ADENYL NUCLEOTIDE BINDING 55 1514 1.007e-06 1.833e-05
52 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 8 43 1.027e-06 1.835e-05
53 HEPARIN BINDING 14 157 1.333e-06 2.337e-05
54 CHROMATIN BINDING 24 435 2.064e-06 3.527e-05
55 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING 8 47 2.088e-06 3.527e-05
56 COLLAGEN BINDING 9 65 2.889e-06 4.793e-05
57 PROTEIN TYROSINE PHOSPHATASE ACTIVITY 11 103 3.182e-06 5.186e-05
58 NEUROTROPHIN RECEPTOR BINDING 5 14 3.632e-06 5.818e-05
59 CYTOSKELETAL PROTEIN BINDING 35 819 3.769e-06 5.934e-05
60 EPHRIN RECEPTOR BINDING 6 24 3.849e-06 5.959e-05
61 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 8 51 3.965e-06 6.039e-05
62 PROTEIN HETERODIMERIZATION ACTIVITY 24 468 7.184e-06 0.0001076
63 TRANSFORMING GROWTH FACTOR BETA BINDING 5 16 7.687e-06 0.0001134
64 ENZYME REGULATOR ACTIVITY 38 959 8.219e-06 0.0001193
65 HISTONE ACETYLTRANSFERASE BINDING 6 28 1.012e-05 0.0001446
66 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 9 76 1.077e-05 0.0001517
67 HMG BOX DOMAIN BINDING 5 18 1.463e-05 0.0002028
68 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 6 30 1.546e-05 0.0002082
69 TUMOR NECROSIS FACTOR RECEPTOR BINDING 6 30 1.546e-05 0.0002082
70 STRUCTURAL CONSTITUENT OF CYTOSKELETON 10 100 1.605e-05 0.000213
71 BINDING BRIDGING 13 173 2.052e-05 0.0002685
72 PROTEIN HOMODIMERIZATION ACTIVITY 30 722 3.223e-05 0.0004159
73 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 11 133 3.68e-05 0.0004683
74 CALCIUM ION BINDING 29 697 4.27e-05 0.000536
75 PEPTIDASE REGULATOR ACTIVITY 14 214 4.656e-05 0.0005767
76 PROTEIN TYROSINE KINASE BINDING 7 54 5.774e-05 0.0007058
77 SIGNALING ADAPTOR ACTIVITY 8 74 6.492e-05 0.0007832
78 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 12 168 6.969e-05 0.00083
79 PROTEIN PHOSPHATASE BINDING 10 120 7.77e-05 0.0009137
80 RECEPTOR SIGNALING PROTEIN ACTIVITY 12 172 8.738e-05 0.001015
81 G PROTEIN COUPLED RECEPTOR BINDING 15 259 0.0001007 0.001155
82 SULFUR COMPOUND BINDING 14 234 0.0001213 0.001358
83 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 12 178 0.0001211 0.001358
84 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 9 104 0.0001322 0.001448
85 CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 4 15 0.0001325 0.001448
86 ACTIN BINDING 19 393 0.0001401 0.001514
87 AMIDE BINDING 15 272 0.0001726 0.001843
88 RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC DNA BINDING 7 65 0.0001908 0.002015
89 EPIDERMAL GROWTH FACTOR RECEPTOR BINDING 5 30 0.0002028 0.002117
90 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 4 17 0.0002243 0.002315
91 PROTEIN SERINE THREONINE KINASE ACTIVITY 20 445 0.0002477 0.002529
92 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 24 588 0.0002598 0.002623
93 INSULIN RECEPTOR BINDING 5 32 0.000278 0.002777
94 VIRUS RECEPTOR ACTIVITY 7 70 0.0003037 0.00297
95 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 8 92 0.0003008 0.00297
96 ENHANCER BINDING 8 93 0.0003239 0.003135
97 NITRIC OXIDE SYNTHASE BINDING 4 19 0.0003548 0.003398
98 ENZYME ACTIVATOR ACTIVITY 20 471 0.0005118 0.004851
99 CORE PROMOTER BINDING 10 152 0.0005342 0.005013
100 CORECEPTOR ACTIVITY 5 38 0.000633 0.005881
101 ENZYME INHIBITOR ACTIVITY 17 378 0.0007063 0.006497
102 HISTONE DEACETYLASE BINDING 8 105 0.0007328 0.006674
103 PHOSPHATASE BINDING 10 162 0.0008759 0.0079
104 MITOGEN ACTIVATED PROTEIN KINASE BINDING 4 24 0.0009044 0.008078
105 ION CHANNEL BINDING 8 111 0.001055 0.0093
106 ACTIN MONOMER BINDING 4 25 0.001061 0.0093
NumGOOverlapSizeP ValueAdj. P Value
1 SIDE OF MEMBRANE 60 428 2.504e-35 1.462e-32
2 CELL SURFACE 65 757 1.274e-25 3.721e-23
3 EXTRACELLULAR SPACE 85 1376 1.233e-23 2.399e-21
4 MEMBRANE MICRODOMAIN 39 288 1.432e-22 2.091e-20
5 EXTRACELLULAR MATRIX 46 426 2.804e-22 3.275e-20
6 EXTERNAL SIDE OF PLASMA MEMBRANE 31 238 1.184e-17 1.153e-15
7 CELL SUBSTRATE JUNCTION 39 398 1.53e-17 1.277e-15
8 ANCHORING JUNCTION 42 489 9.848e-17 7.189e-15
9 CELL JUNCTION 64 1151 1.694e-15 1.099e-13
10 PROTEINACEOUS EXTRACELLULAR MATRIX 34 356 4.329e-15 2.528e-13
11 CYTOPLASMIC SIDE OF MEMBRANE 24 170 9.872e-15 5.241e-13
12 INTRACELLULAR VESICLE 64 1259 1.095e-13 5.33e-12
13 PLATELET ALPHA GRANULE 16 75 4.148e-13 1.864e-11
14 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 20 136 7.899e-13 3.295e-11
15 PLATELET ALPHA GRANULE LUMEN 14 55 9.096e-13 3.541e-11
16 EXTRINSIC COMPONENT OF MEMBRANE 26 252 1.384e-12 5.028e-11
17 MEMBRANE REGION 58 1134 1.464e-12 5.028e-11
18 EXTRACELLULAR MATRIX COMPONENT 19 125 1.624e-12 5.27e-11
19 VACUOLE 58 1180 7.389e-12 2.271e-10
20 RECEPTOR COMPLEX 28 327 1.735e-11 5.066e-10
21 ENDOSOME 45 793 2.152e-11 5.985e-10
22 CYTOPLASMIC VESICLE PART 38 601 4.003e-11 1.063e-09
23 PLASMA MEMBRANE RECEPTOR COMPLEX 20 175 8.936e-11 2.175e-09
24 CELL LEADING EDGE 28 350 8.58e-11 2.175e-09
25 VESICLE LUMEN 16 106 1.065e-10 2.487e-09
26 PLASMA MEMBRANE PROTEIN COMPLEX 34 510 1.121e-10 2.518e-09
27 COMPLEX OF COLLAGEN TRIMERS 9 23 1.463e-10 3.163e-09
28 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 15 98 3.355e-10 6.998e-09
29 CELL PROJECTION 71 1786 4.251e-10 8.561e-09
30 SECRETORY GRANULE LUMEN 14 85 4.812e-10 9.368e-09
31 INTRINSIC COMPONENT OF PLASMA MEMBRANE 67 1649 5.971e-10 1.125e-08
32 NEURON PROJECTION 45 942 5.212e-09 9.512e-08
33 ENDOCYTIC VESICLE 21 256 1.331e-08 2.356e-07
34 ENDOCYTIC VESICLE MEMBRANE 16 152 2.291e-08 3.935e-07
35 BANDED COLLAGEN FIBRIL 6 12 3.187e-08 5.318e-07
36 ENDOPLASMIC RETICULUM LUMEN 18 201 3.852e-08 6.249e-07
37 SECRETORY GRANULE 24 352 4.424e-08 6.983e-07
38 NEURON PART 52 1265 4.653e-08 7.151e-07
39 AXON 26 418 7.607e-08 1.139e-06
40 MYELIN SHEATH 16 168 9.423e-08 1.369e-06
41 PHAGOCYTIC VESICLE MEMBRANE 10 58 9.609e-08 1.369e-06
42 SECRETORY VESICLE 27 461 1.44e-07 1.956e-06
43 BASEMENT MEMBRANE 12 93 1.416e-07 1.956e-06
44 PHAGOCYTIC VESICLE 11 86 5.161e-07 6.85e-06
45 COLLAGEN TRIMER 11 88 6.533e-07 8.479e-06
46 SOMATODENDRITIC COMPARTMENT 31 650 1.512e-06 1.919e-05
47 MEMBRANE PROTEIN COMPLEX 41 1020 2.478e-06 3.079e-05
48 VESICLE MEMBRANE 26 512 3.55e-06 4.319e-05
49 LAMELLIPODIUM 14 172 3.933e-06 4.688e-05
50 CELL BODY 25 494 5.819e-06 6.797e-05
51 CYTOPLASMIC REGION 18 287 7.064e-06 8.089e-05
52 CELL CORTEX 16 238 9.625e-06 0.0001081
53 IMMUNOLOGICAL SYNAPSE 6 33 2.753e-05 0.0003033
54 SYNAPSE 31 754 2.904e-05 0.0003141
55 PLASMA MEMBRANE RAFT 9 86 2.958e-05 0.0003141
56 LEADING EDGE MEMBRANE 11 134 3.944e-05 0.0004113
57 GOLGI APPARATUS 48 1445 5.362e-05 0.0005494
58 MHC PROTEIN COMPLEX 5 27 0.0001202 0.00119
59 PLASMA MEMBRANE REGION 34 929 0.0001198 0.00119
60 ENDOSOMAL PART 20 430 0.0001579 0.001512
61 RUFFLE 11 156 0.0001557 0.001512
62 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 5 30 0.0002028 0.00191
63 VACUOLAR PART 27 694 0.0002343 0.002171
64 ACTIN CYTOSKELETON 20 444 0.0002406 0.002195
65 CELL CELL JUNCTION 18 383 0.0002944 0.002607
66 DENDRITE 20 451 0.0002946 0.002607
67 LUMENAL SIDE OF MEMBRANE 5 33 0.0003228 0.002813
68 ER TO GOLGI TRANSPORT VESICLE 7 71 0.0003317 0.002848
69 GOLGI LUMEN 8 94 0.0003485 0.002949
70 CELL PROJECTION PART 33 946 0.0003592 0.002997
71 PERINUCLEAR REGION OF CYTOPLASM 25 642 0.0003921 0.003225
72 TRANSCRIPTION FACTOR COMPLEX 15 298 0.000457 0.003707
73 POSTSYNAPSE 17 378 0.0007063 0.005651
74 AXON PART 12 219 0.0008002 0.006315
75 ENDOPLASMIC RETICULUM 48 1631 0.0008673 0.006754
76 MHC CLASS I PROTEIN COMPLEX 3 11 0.0009207 0.007075
77 INFLAMMASOME COMPLEX 3 12 0.001211 0.009184
78 VACUOLAR LUMEN 8 115 0.001326 0.009931

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04014_Ras_signaling_pathway 43 236 3.018e-30 5.432e-28
2 hsa04510_Focal_adhesion 39 200 1.13e-28 1.017e-26
3 hsa04151_PI3K_AKT_signaling_pathway 47 351 7.862e-27 4.717e-25
4 hsa04010_MAPK_signaling_pathway 38 268 9.691e-23 4.361e-21
5 hsa04660_T_cell_receptor_signaling_pathway 24 108 1.805e-19 6.499e-18
6 hsa04350_TGF.beta_signaling_pathway 19 85 1.002e-15 3.005e-14
7 hsa04380_Osteoclast_differentiation 22 128 1.923e-15 4.944e-14
8 hsa04390_Hippo_signaling_pathway 23 154 1.037e-14 2.332e-13
9 hsa04062_Chemokine_signaling_pathway 25 189 1.269e-14 2.538e-13
10 hsa04722_Neurotrophin_signaling_pathway 21 127 1.895e-14 3.411e-13
11 hsa04810_Regulation_of_actin_cytoskeleton 26 214 2.915e-14 4.77e-13
12 hsa04650_Natural_killer_cell_mediated_cytotoxicity 21 136 7.755e-14 1.163e-12
13 hsa04012_ErbB_signaling_pathway 17 87 3.523e-13 4.877e-12
14 hsa04670_Leukocyte_transendothelial_migration 19 117 4.764e-13 6.125e-12
15 hsa04512_ECM.receptor_interaction 16 85 3.229e-12 3.874e-11
16 hsa04520_Adherens_junction 14 73 5.72e-11 6.435e-10
17 hsa04630_Jak.STAT_signaling_pathway 18 155 6.08e-10 6.437e-09
18 hsa04664_Fc_epsilon_RI_signaling_pathway 13 79 2.046e-09 2.046e-08
19 hsa04620_Toll.like_receptor_signaling_pathway 14 102 5.672e-09 5.373e-08
20 hsa04144_Endocytosis 19 203 7.794e-09 7.015e-08
21 hsa04145_Phagosome 16 156 3.318e-08 2.844e-07
22 hsa04640_Hematopoietic_cell_lineage 12 88 7.585e-08 6.206e-07
23 hsa04621_NOD.like_receptor_signaling_pathway 10 59 1.138e-07 8.907e-07
24 hsa04662_B_cell_receptor_signaling_pathway 11 75 1.238e-07 9.288e-07
25 hsa04514_Cell_adhesion_molecules_.CAMs. 14 136 2.302e-07 1.657e-06
26 hsa04916_Melanogenesis 12 101 3.551e-07 2.458e-06
27 hsa04612_Antigen_processing_and_presentation 10 78 1.67e-06 1.114e-05
28 hsa04912_GnRH_signaling_pathway 11 101 2.62e-06 1.684e-05
29 hsa04672_Intestinal_immune_network_for_IgA_production 8 49 2.9e-06 1.8e-05
30 hsa04310_Wnt_signaling_pathway 13 151 4.702e-06 2.787e-05
31 hsa04115_p53_signaling_pathway 9 69 4.8e-06 2.787e-05
32 hsa04210_Apoptosis 10 89 5.64e-06 3.173e-05
33 hsa04666_Fc_gamma_R.mediated_phagocytosis 10 95 1.016e-05 5.544e-05
34 hsa04974_Protein_digestion_and_absorption 9 81 1.82e-05 9.633e-05
35 hsa04360_Axon_guidance 11 130 2.977e-05 0.0001531
36 hsa04914_Progesterone.mediated_oocyte_maturation 9 87 3.247e-05 0.0001623
37 hsa04540_Gap_junction 9 90 4.259e-05 0.0002072
38 hsa04910_Insulin_signaling_pathway 11 138 5.17e-05 0.0002449
39 hsa04110_Cell_cycle 10 128 0.0001334 0.0006155
40 hsa04150_mTOR_signaling_pathway 6 52 0.0003768 0.001696
41 hsa04370_VEGF_signaling_pathway 7 76 0.000504 0.002213
42 hsa04920_Adipocytokine_signaling_pathway 6 68 0.001583 0.006784
43 hsa04610_Complement_and_coagulation_cascades 6 69 0.001707 0.007147
44 hsa04070_Phosphatidylinositol_signaling_system 6 78 0.003186 0.01303
45 hsa04530_Tight_junction 8 133 0.003305 0.01322
46 hsa04340_Hedgehog_signaling_pathway 5 56 0.003677 0.01439
47 hsa00562_Inositol_phosphate_metabolism 5 57 0.00397 0.01521
48 hsa04960_Aldosterone.regulated_sodium_reabsorption 4 42 0.007344 0.02754
49 hsa04973_Carbohydrate_digestion_and_absorption 4 44 0.008655 0.03179
50 hsa04730_Long.term_depression 5 70 0.009456 0.03404
51 hsa04622_RIG.I.like_receptor_signaling_pathway 5 71 0.01002 0.03537
52 hsa04320_Dorso.ventral_axis_formation 3 25 0.0106 0.0367
53 hsa04330_Notch_signaling_pathway 4 47 0.01089 0.03699
54 hsa04720_Long.term_potentiation 4 70 0.04039 0.1346
55 hsa04020_Calcium_signaling_pathway 7 177 0.04632 0.1516
56 hsa04114_Oocyte_meiosis 5 114 0.06016 0.1934
57 hsa04270_Vascular_smooth_muscle_contraction 5 116 0.06385 0.2016
58 hsa04972_Pancreatic_secretion 4 101 0.1168 0.3626
59 hsa03320_PPAR_signaling_pathway 3 70 0.1391 0.4173
60 hsa04971_Gastric_acid_secretion 3 74 0.1565 0.4617
61 hsa04962_Vasopressin.regulated_water_reabsorption 2 44 0.1947 0.5564
62 hsa04970_Salivary_secretion 3 89 0.2265 0.6369
63 hsa00330_Arginine_and_proline_metabolism 2 54 0.2628 0.7279
64 hsa04623_Cytosolic_DNA.sensing_pathway 2 56 0.2766 0.743
65 hsa04142_Lysosome 3 121 0.3867 1
66 hsa04141_Protein_processing_in_endoplasmic_reticulum 3 168 0.602 1
67 hsa04120_Ubiquitin_mediated_proteolysis 2 139 0.7296 1

Quest ID: db257ebee19abd0f1a6da92c0e79b82d